ENTRY,FORMULA,mol_weight,exact_mass,pathway,name,reaction,enzyme,brite,dblinks
C00097,C3H7NO2S,121.1582,121.0197,"Glycine, serine and threonine metabolism;Cysteine and methionine metabolism;Penicillin and cephalosporin biosynthesis;Carbapenem biosynthesis;Taurine and hypotaurine metabolism;Cyanoamino acid metabolism;Glutathione metabolism;Thiamine metabolism;Pantothenate and CoA biosynthesis;Sulfur metabolism;Aminoacyl-tRNA biosynthesis;Biosynthesis of plant secondary metabolites;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of antibiotics;Carbon metabolism;Biosynthesis of amino acids;Sulfur relay system;Ferroptosis;Protein digestion and absorption;Central carbon metabolism in cancer",L-Cysteine;L-2-Amino-3-mercaptopropionic acid,R00782 R00891 R00892 R00893 R00894 R00895 R00896 R00897;R00899 R00900 R00901 R00903 R01001 R01113 R02409 R02508;R02743 R03217 R03260 R03524 R03650 R03923 R04230 R04231;R04859 R04870 R07274 R07360 R07460 R08168 R08608 R08632;R08653 R08659 R08666 R08685 R08848 R09562 R09591 R10409;R10670 R10672 R10736 R11014 R11015 R11524 R11528 R11583,R00782 R00891 R00892 R00893 R00894 R00895 R00896 R00897;R00899 R00900 R00901 R00903 R01001 R01113 R02409 R02508;R02743 R03217 R03260 R03524 R03650 R03923 R04230 R04231;R04859 R04870 R07274 R07360 R07460 R08168 R08608 R08632;R08653 R08659 R08666 R08685 R08848 R09562 R09591 R10409;R10670 R10672 R10736 R11014 R11015 R11524 R11528 R11583,Compounds with biological roles [BR:br08001]; Peptides;  Amino acids;   Common amino acids;    C00097  Cysteine (Cys);Therapeutic category of drugs in Japan [BR:br08301]; 3  Agents affecting metabolism;  39  Other agents affecting metabolism;   399  Miscellaneous;    3999  Others;     D00026  L-Cysteine (JP17);Classification of Japanese OTC drugs [BR:br08313]; Nourishing tonics and health supplements;  45 Protein and amino acid based drugs;   D00026  L-Cysteine (JP17);Risk category of Japanese OTC drugs [BR:br08312]; Third-class OTC drugs;  Inorganic and organic chemicals;   L-Cysteine;    D00026  L-Cysteine (JP17);Pharmaceutical additives in Japan [BR:br08316]; Stabilizing agent;  D00026  [003614] L-Cysteine;Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D00026  L-Cysteine,CAS: 52-90-4;PubChem: 3397;ChEBI: 17561;ChEMBL: CHEMBL863;KNApSAcK: C00001351;PDB-CCD: CYS;3DMET: B01159;NIKKAJI: J9.167G
C02835,C5H6N2O2,126.1133,126.0429,Histidine metabolism,Imidazole-4-acetate;Imidazoleacetic acid;4-Imidazoleacetate,R04065 R04066 R04068,R04065 R04066 R04068,,CAS: 645-65-8;PubChem: 5778;ChEBI: 16974;ChEMBL: CHEMBL784;3DMET: B00507;NIKKAJI: J38.564F
C00036,C4H4O5,132.0716,132.0059,"Glycolysis / Gluconeogenesis;Citrate cycle (TCA cycle);Alanine, aspartate and glutamate metabolism;Benzoate degradation;Pyruvate metabolism;Glyoxylate and dicarboxylate metabolism;Methane metabolism;Carbon fixation in photosynthetic organisms;Carbon fixation pathways in prokaryotes;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of terpenoids and steroids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid;Biosynthesis of alkaloids derived from histidine and purine;Biosynthesis of alkaloids derived from terpenoid and polyketide;Biosynthesis of plant hormones;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of antibiotics;Carbon metabolism;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids;Two-component system;Glucagon signaling pathway;Proximal tubule bicarbonate reclamation;Central carbon metabolism in cancer",Oxaloacetate;Oxalacetic acid;Oxaloacetic acid;2-Oxobutanedioic acid;2-Oxosuccinic acid;keto-Oxaloacetate,R00217 R00338 R00339 R00340 R00341 R00342 R00343 R00344;R00345 R00346 R00347 R00348 R00350 R00351 R00352 R00353;R00354 R00355 R00357 R00359 R00360 R00361 R00362 R00363;R00373 R00400 R00431 R00477 R00493 R00695 R00726 R00930;R00931 R01144 R01257 R01447 R01713 R01731 R03735 R05053;R05758 R07164 R07165 R09683 R12212,R00217 R00338 R00339 R00340 R00341 R00342 R00343 R00344;R00345 R00346 R00347 R00348 R00350 R00351 R00352 R00353;R00354 R00355 R00357 R00359 R00360 R00361 R00362 R00363;R00373 R00400 R00431 R00477 R00493 R00695 R00726 R00930;R00931 R01144 R01257 R01447 R01713 R01731 R03735 R05053;R05758 R07164 R07165 R09683 R12212,Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   2-Oxocarboxylic acids;    C00036  Oxaloacetate; 2-Oxosuccinate,CAS: 328-42-7;PubChem: 3338;ChEBI: 16452 30744;ChEMBL: CHEMBL1794791;KNApSAcK: C00001197;PDB-CCD: OAA;3DMET: B00010;NIKKAJI: J5.675H
C00077,C5H12N2O2,132.161,132.0899,"Arginine biosynthesis;Arginine and proline metabolism;D-Arginine and D-ornithine metabolism;Glutathione metabolism;Biosynthesis of secondary metabolites - unclassified;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid;Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of antibiotics;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids;ABC transporters","L-Ornithine;(S)-2,5-Diaminovaleric acid;(S)-2,5-Diaminopentanoic acid;(S)-2,5-Diaminopentanoate",R00551 R00565 R00664 R00665 R00666 R00667 R00668 R00669;R00670 R00671 R00672 R01343 R01398 R01686 R01989 R02282;R03477 R05547 R10466 R10789 R10790 R10933 R11801,R00551 R00565 R00664 R00665 R00666 R00667 R00668 R00669;R00670 R00671 R00672 R01343 R01398 R01686 R01989 R02282;R03477 R05547 R10466 R10789 R10790 R10933 R11801,Compounds with biological roles [BR:br08001]; Peptides;  Amino acids;   Other amino acids;    C00077  L-Ornithine,CAS: 70-26-8;PubChem: 3377;ChEBI: 15729;ChEMBL: CHEMBL446143;KNApSAcK: C00001384;PDB-CCD: ORN;3DMET: B00020;NIKKAJI: J9.177D
C01046,C6H11NO4,161.1558,161.0688,Methane metabolism;Microbial metabolism in diverse environments,N-Methyl-L-glutamate;N-Methyl-L-glutamic acid,R00609 R01586,R00609 R01586,,PubChem: 4288;ChEBI: 16440;PDB-CCD: EME;3DMET: B01370;NIKKAJI: J253.918G
C00715,C6H5N5O,163.1368,163.0494,,Pterin;2-Amino-4-oxopteridine;2-Amino-4-hydroxypteridine,R02815 R02816,R02815 R02816,,CAS: 2236-60-4;PubChem: 3981;ChEBI: 26374 44992;ChEMBL: CHEMBL278009;PDB-CCD: PE0;3DMET: B00159;NIKKAJI: J38.136E
C00111,C3H7O6P,170.0578,169.998,Glycolysis / Gluconeogenesis;Pentose and glucuronate interconversions;Fructose and mannose metabolism;Galactose metabolism;Glycerolipid metabolism;Inositol phosphate metabolism;Glycerophospholipid metabolism;Propanoate metabolism;Methane metabolism;Carbon fixation in photosynthetic organisms;Nicotinate and nicotinamide metabolism;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of antibiotics;Carbon metabolism;Biosynthesis of amino acids,Glycerone phosphate;Dihydroxyacetone phosphate;3-Hydroxy-2-oxopropyl phosphate,R00842 R00844 R00846 R00848 R00849 R01010 R01011 R01012;R01013 R01014 R01015 R01016 R01068 R01069 R01070 R01785;R01829 R02262 R02263 R02568 R04292 R05378 R05679 R05680;R08650 R08657 R10673 R10760 R11182 R11716 R11717 R11724;R11726,R00842 R00844 R00846 R00848 R00849 R01010 R01011 R01012;R01013 R01014 R01015 R01016 R01068 R01069 R01070 R01785;R01829 R02262 R02263 R02568 R04292 R05378 R05679 R05680;R08650 R08657 R10673 R10760 R11182 R11716 R11717 R11724;R11726,,CAS: 57-04-5;PubChem: 3411;ChEBI: 16108;ChEMBL: CHEMBL1161998;KNApSAcK: C00007560;PDB-CCD: 13P;3DMET: B00029;NIKKAJI: J213.543D
C00072,C6H8O6,176.1241,176.0321,Ascorbate and aldarate metabolism;Glutathione metabolism;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phosphotransferase system (PTS);HIF-1 signaling pathway;Vitamin digestion and absorption,Ascorbate;Ascorbic acid;L-Ascorbate;L-Ascorbic acid;Vitamin C,R00068 R00095 R00640 R00643 R00644 R00645 R00646 R00647;R01108 R02535 R03147 R03186 R03912 R07178 R07179 R07214;R07671 R07679 R08358 R09540 R09739 R10053 R10055,R00068 R00095 R00640 R00643 R00644 R00645 R00646 R00647;R01108 R02535 R03147 R03186 R03912 R07178 R07179 R07214;R07671 R07679 R08358 R09540 R09739 R10053 R10055,"Compounds with biological roles [BR:br08001]; Vitamins and Cofactors;  Vitamins;   Water-soluble vitamins;    C00072  Ascorbic acid (Vitamin C);Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; A ALIMENTARY TRACT AND METABOLISM;  A11 VITAMINS;   A11G ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS;    A11GA Ascorbic acid (vitamin C), plain;     A11GA01 Ascorbic acid (vit C);      D00018  Ascorbic acid (JP17/USP/INN) &lt;JP/US&gt;; G GENITO URINARY SYSTEM AND SEX HORMONES;  G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS;   G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS;    G01AD Organic acids;     G01AD03 Ascorbic acid;      D00018  Ascorbic acid (JP17/USP/INN) &lt;JP/US&gt;; S SENSORY ORGANS;  S01 OPHTHALMOLOGICALS;   S01X OTHER OPHTHALMOLOGICALS;    S01XA Other ophthalmologicals;     S01XA15 Ascorbic acid;      D00018  Ascorbic acid (JP17/USP/INN) &lt;JP/US&gt;;Therapeutic category of drugs in Japan [BR:br08301]; 3  Agents affecting metabolism;  31  Vitamins;   314  Vitamin C preparations;    3140  Vitamin C preparations;     D00018  Ascorbic acid (JP17/USP/INN);Classification of Japanese OTC drugs [BR:br08313]; Nourishing tonics and health supplements;  38 Vitamin C based drugs;   D00018  Ascorbic acid (JP17/USP/INN);  41 Vitamin EC based drugs;   D00018  Ascorbic acid (JP17/USP/INN);  43 Vitamin containing supplements;   D00018  Ascorbic acid (JP17/USP/INN);Risk category of Japanese OTC drugs [BR:br08312]; Third-class OTC drugs;  Inorganic and organic chemicals;   Ascorbic acid;    D00018  Ascorbic acid (JP17/USP/INN);Pharmaceutical additives in Japan [BR:br08316]; Stabilizing agent;  D00018  [001008] Ascorbic acid; Buffering agent;  D00018  [001008] Ascorbic acid; Flavoring substance;  D00018  [001008] Ascorbic acid; Antioxidant agent;  D00018  [001008] Ascorbic acid;Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D00018  Ascorbic acid;  D00018  Ascorbic acid powder;  D00018  Ascorbic acid injection;Animal drugs in Japan [BR:br08331]; 96  Agents affecting metabolism;  962  Vitamin preparations;   9624  Vitamin C and preparations;    C00072  Ascorbate;Major components of natural products [BR:br08323]; Medicinal herbs;  Cranberry;   C00072  Ascorbate;  Rose hip;   C00072  Ascorbate",CAS: 50-81-7;PubChem: 3372;ChEBI: 29073 38290;ChEMBL: CHEMBL196;KNApSAcK: C00001179;PDB-CCD: ASC;3DMET: B01147;NIKKAJI: J2.301I
C00095,C6H12O6,180.1559,180.0634,Fructose and mannose metabolism;Galactose metabolism;Starch and sucrose metabolism;Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Phosphotransferase system (PTS);Taste transduction;Insulin resistance;Carbohydrate digestion and absorption,D-Fructose;Levulose;Fruit sugar;D-arabino-Hexulose,R00307 R00760 R00801 R00803 R00806 R00865 R00866 R00867;R00868 R00870 R00872 R00873 R00874 R00875 R00876 R00877;R00878 R00879 R01140 R01823 R02120 R02410 R03232 R03635;R03921 R06034 R06036 R06052 R06066 R06087 R06100 R06101;R06208 R08406 R08407 R08548 R08651 R08676 R10817,R00307 R00760 R00801 R00803 R00806 R00865 R00866 R00867;R00868 R00870 R00872 R00873 R00874 R00875 R00876 R00877;R00878 R00879 R01140 R01823 R02120 R02410 R03232 R03635;R03921 R06034 R06036 R06052 R06066 R06087 R06100 R06101;R06208 R08406 R08407 R08548 R08651 R08676 R10817,Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Ketoses;    C00095  D-Fructose; Fruit sugar;Animal drugs in Japan [BR:br08331]; 96  Agents affecting metabolism;  964  Saccharide preparations and blood substitutes;   9642  Fructose and preparations;    C00095  D-Fructose,CAS: 57-48-7;PubChem: 3395;ChEBI: 15824 37721;ChEMBL: CHEMBL604608;KNApSAcK: C00033848;PDB-CCD: FRU;3DMET: B04631;NIKKAJI: J4.580B
C00725,C8H14O2S2,206.3256,206.0435,,Lipoate;Lipoic acid;Thioctic acid;dl-alpha-Lipoic acid;DL-Thioctic acid,,,Compounds with biological roles [BR:br08001]; Vitamins and Cofactors;  Cofactors;   Coenzymes;    C00725  Lipoate;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; A ALIMENTARY TRACT AND METABOLISM;  A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;   A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS;    A16AX Various alimentary tract and metabolism products;     A16AX01 Thioctic acid;      D00086  Thioctic acid (JAN) &lt;JP&gt;;Therapeutic category of drugs in Japan [BR:br08301]; 3  Agents affecting metabolism;  39  Other agents affecting metabolism;   399  Miscellaneous;    3999  Others;     D00086  Thioctic acid (JAN);Classification of Japanese OTC drugs [BR:br08313]; Nourishing tonics and health supplements;  43 Vitamin containing supplements;   D00086  Thioctic acid (JAN);Risk category of Japanese OTC drugs [BR:br08312]; Third-class OTC drugs;  Inorganic and organic chemicals;   Thioctic acid;    D00086  Thioctic acid (JAN);Animal drugs in Japan [BR:br08331]; 96  Agents affecting metabolism;  967  Agents for liver disease and antidotes;   9679  Other agents for liver disease and antidotes;    C00725  Thioctic acid,CAS: 62-46-4;PubChem: 3990;ChEBI: 16494 30314;ChEMBL: CHEMBL33864;LIPIDMAPS: LMFA01130001;3DMET: B00160;NIKKAJI: J38.321J
C00214,C10H14N2O5,242.2286,242.0903,Pyrimidine metabolism;Metabolic pathways,Thymidine;Deoxythymidine,R01567 R01568 R01569 R01570 R01571 R02806,R01567 R01568 R01569 R01570 R01571 R02806,Compounds with biological roles [BR:br08001]; Nucleic acids;  Nucleosides;   Deoxyribonucleosides;    C00214  Deoxythymidine (dT),CAS: 50-89-5;PubChem: 3514;ChEBI: 17748;ChEMBL: CHEMBL52609;KNApSAcK: C00019698;PDB-CCD: THM;3DMET: B01191;NIKKAJI: J4.548I
C01817,C8H16N2O4S2,268.3536,268.0551,Cysteine and methionine metabolism,L-Homocystine;Homocystine,R01292,R01292,,CAS: 626-72-2;PubChem: 4941;ChEBI: 141698 17485;3DMET: B01502;NIKKAJI: J5.770C
C02494,C11H15N5O4,281.2679,281.1124,,1-Methyladenosine,R03885,R03885,,CAS: 15763-06-1;PubChem: 5506;ChEBI: 16020;ChEMBL: CHEMBL1866485;NIKKAJI: J130.848C
C16526,C20H38O2,310.5145,310.2872,Biosynthesis of unsaturated fatty acids,Icosenoic acid;Eicosenoic acid;11-Icosenoic acid;11-Eicosenoic acid;(11Z)-Icosenoic acid;(11Z)-Eicosenoic acid;(Z)-Icosa-11-enoic acid,R08186,R08186,Compounds with biological roles [BR:br08001]; Lipids;  Fatty acids;   Unsaturated fatty acids;    C16526  Icosenoic acid (20:1;11);Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0103 Unsaturated fatty acids;    Monounsaturated fatty acids;     C16526  (Z)-Icos-11-enoic acid,PubChem: 51090855;ChEBI: 32425;LIPIDMAPS: LMFA01030085;LipidBank: DFA0124;KNApSAcK: C00035628;NIKKAJI: J12.741H
C20792,C20H39NO2,325.5292,325.2981,cAMP signaling pathway,Oleoylethanolamide;OEA,,,,CAS: 111-58-0;PubChem: 254741259;ChEMBL: CHEMBL280065
C08320,C24H48O2,368.6367,368.3654,Biosynthesis of unsaturated fatty acids,Tetracosanoic acid;Lignoceric acid,R08185,R08185,Compounds with biological roles [BR:br08001]; Lipids;  Fatty acids;   Saturated fatty acids;    C08320  Lignoceric acid (24:0);Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0101 Straight chain fatty acids;    C08320  Tetracosanoic acid,CAS: 557-59-5;PubChem: 10518;ChEBI: 28866;ChEMBL: CHEMBL1173620;LIPIDMAPS: LMFA01010024;LipidBank: DFA0024;KNApSAcK: C00001223;3DMET: B02164;NIKKAJI: J11.350F
C03990,C24H40O3,376.5726,376.2977,Secondary bile acid biosynthesis;Bile secretion,Lithocholic acid;Lithocholate;3alpha-Hydroxy-5beta-cholanate;3alpha-Hydroxy-5beta-cholanic acid,R03978 R04139 R07203 R07206 R11145 R11539,R03978 R04139 R07203 R07206 R11145 R11539,"Compounds with biological roles [BR:br08001]; Steroids;  24-Carbon atoms;   Cholane derivatives;    C03990  Lithocholic acid;Lipids [BR:br08002]; ST  Sterol Lipids;  ST04 Bile acids and derivatives;   ST0401 C24 bile acids, alcohols, and derivatives;    C03990  3alpha-Hydroxy-5beta-cholanic acid",CAS: 434-13-9;PubChem: 6705;ChEBI: 16325;ChEMBL: CHEMBL1478 CHEMBL3137668 CHEMBL3348901;LIPIDMAPS: LMST04010003;LipidBank: BBA0003;PDB-CCD: 4OA;3DMET: B01708;NIKKAJI: J1.532F
C12272,C26H43NO3,417.6245,417.3243,Neuroactive ligand-receptor interaction,N-Oleoyl dopamine,,,,PubChem: 14417;ChEBI: 31883;ChEMBL: CHEMBL250711;NIKKAJI: J467.921K
C03204,C20H21N7O7,471.4234,471.1502,,10-Formyldihydrofolate,R02238,R02238,,CAS: 28459-40-7;PubChem: 6080;ChEBI: 15634;NIKKAJI: J527.535K
C00010,C21H36N7O16P3S,767.5341,767.1152,Fatty acid degradation;Carbapenem biosynthesis;Pantothenate and CoA biosynthesis;Metabolic pathways;Biosynthesis of antibiotics;Ferroptosis;Thermogenesis;Cholinergic synapse;Fat digestion and absorption;Vitamin digestion and absorption,CoA;Coenzyme A;CoA-SH,R00091 R00130 R00209 R00210 R00211 R00212 R00227 R00228;R00229 R00230 R00235 R00236 R00238 R00259 R00265 R00271;R00351 R00352 R00371 R00383 R00389 R00390 R00391 R00394;R00395 R00399 R00405 R00407 R00432 R00454 R00468 R00472;R00487 R00521 R00577 R00586 R00627 R00664 R00693 R00705;R00706 R00727 R00740 R00829 R00830 R00832 R00851 R00918;R00920 R00921 R00922 R00925 R00926 R00927 R00931 R00932;R00935 R00982 R00989 R00998 R01013 R01023 R01075 R01089;R01111 R01154 R01160 R01172 R01173 R01174 R01176 R01177;R01180 R01196 R01197 R01199 R01204 R01210 R01213 R01256;R01274 R01277 R01280 R01281 R01300 R01301 R01318 R01319;R01322 R01357 R01358 R01368 R01422 R01461 R01496 R01556;R01558 R01598 R01613 R01614 R01615 R01616 R01617 R01624;R01625 R01626 R01651 R01776 R01777 R01798 R01806 R01807;R01808 R01850 R01889 R01923 R01933 R01941 R01943 R01944;R01945 R01946 R01952 R01978 R01999 R02058 R02081 R02082;R02083 R02138 R02152 R02191 R02193 R02194 R02195 R02220;R02221 R02224 R02241 R02242 R02251 R02255 R02366 R02367;R02375 R02385 R02387 R02396 R02402 R02404 R02405 R02406;R02416 R02447 R02450 R02452 R02453 R02481 R02482 R02505;R02506 R02539 R02543 R02569 R02570 R02571 R02576 R02616;R02617 R02620 R02662 R02694 R02699 R02760 R02764 R02772;R02794 R02837 R02899 R02911 R02986 R03017 R03040 R03056;R03064 R03065 R03109 R03157 R03158 R03168 R03171 R03174;R03209 R03210 R03230 R03352 R03374 R03381 R03383 R03437;R03438 R03455 R03552 R03621 R03631 R03668 R03695 R03718;R03719 R03720 R03727 R03735 R03755 R03756 R03760 R03762;R03767 R03778 R03779 R03838 R03858 R03859 R03861 R03903;R03910 R03932 R03965 R03974 R03991 R03992 R03994 R04021;R04022 R04024 R04030 R04050 R04097 R04150 R04157 R04192;R04205 R04211 R04254 R04316 R04348 R04356 R04361 R04363;R04364 R04365 R04413 R04466 R04480 R04484 R04507 R04546;R04580 R04618 R04709 R04723 R04742 R04747 R04776 R04777;R04811 R04868 R04950 R05063 R05064 R05129 R05163 R05188;R05189 R05190 R05330 R05331 R05332 R05351 R05451 R05452;R05455 R05506 R05537 R05546 R05586 R05587 R05620 R05672;R05714 R05744 R05841 R05870 R05876 R05918 R06251 R06307;R06310 R06311 R06361 R06367 R06368 R06396 R06409 R06410;R06414 R06415 R06448 R06453 R06458 R06459 R06480 R06481;R06482 R06483 R06510 R06515 R06517 R06527 R06544 R06545;R06568 R06569 R06583 R06624 R06625 R06635 R06637 R06641;R06643 R06644 R06645 R06731 R06735 R06736 R06796 R06797;R06799 R06800 R06801 R06806 R06817 R06821 R06872 R06908;R06944 R06978 R06987 R06997 R07160 R07161 R07175 R07249;R07250 R07251 R07252 R07253 R07255 R07262 R07294 R07296;R07382 R07399 R07416 R07432 R07433 R07719 R07721 R07731;R07741 R07754 R07757 R07758 R07815 R07828 R07833 R07873;R07876 R07880 R07881 R07882 R07883 R07884 R07885 R07886;R07887 R07891 R07895 R07899 R07902 R07910 R07926 R07927;R07928 R07929 R07930 R07931 R07937 R07938 R07944 R07953;R07987 R07988 R07989 R08036 R08088 R08091 R08095 R08097;R08117 R08171 R08172 R08174 R08175 R08176 R08177 R08178;R08179 R08180 R08181 R08182 R08183 R08184 R08185 R08186;R08187 R08188 R08189 R08190 R08191 R08192 R08213 R08248;R08250 R08273 R08331 R08332 R08381 R08386 R08423 R08430;R08432 R08433 R08453 R08530 R08531 R08532 R08549 R08566;R08567 R08619 R08623 R08627 R08631 R08640 R08644 R08680;R08712 R08713 R08733 R08738 R08743 R08744 R08745 R08767;R08796 R08797 R08805 R08806 R08807 R08808 R08809 R08810;R08870 R08871 R08938 R08983 R09034 R09035 R09036 R09037;R09096 R09097 R09106 R09255 R09256 R09257 R09258 R09279;R09280 R09286 R09317 R09419 R09450 R09470 R09524 R09527;R09528 R09557 R09589 R09621 R09622 R09631 R09643 R09839;R09840 R09842 R09854 R09873 R10003 R10099 R10100 R10104;R10142 R10171 R10172 R10173 R10174 R10200 R10210 R10219;R10233 R10234 R10237 R10238 R10239 R10243 R10253 R10254;R10278 R10473 R10474 R10484 R10485 R10500 R10514 R10516;R10526 R10529 R10589 R10590 R10612 R10681 R10700 R10707;R10745 R10746 R10747 R10758 R10769 R10770 R10771 R10820;R10825 R10866 R10893 R10936 R10947 R10960 R10965 R10967;R10998 R11124 R11125 R11182 R11199 R11200 R11201 R11370;R11390 R11412 R11435 R11445 R11450 R11451 R11479 R11516;R11542 R11550 R11584 R11586 R11588 R11615 R11616 R11632;R11664 R11667 R11701 R11708 R11723 R11781 R11782 R11902;R11926 R11957 R11958 R12039 R12042 R12049 R12085 R12117;R12159,R00091 R00130 R00209 R00210 R00211 R00212 R00227 R00228;R00229 R00230 R00235 R00236 R00238 R00259 R00265 R00271;R00351 R00352 R00371 R00383 R00389 R00390 R00391 R00394;R00395 R00399 R00405 R00407 R00432 R00454 R00468 R00472;R00487 R00521 R00577 R00586 R00627 R00664 R00693 R00705;R00706 R00727 R00740 R00829 R00830 R00832 R00851 R00918;R00920 R00921 R00922 R00925 R00926 R00927 R00931 R00932;R00935 R00982 R00989 R00998 R01013 R01023 R01075 R01089;R01111 R01154 R01160 R01172 R01173 R01174 R01176 R01177;R01180 R01196 R01197 R01199 R01204 R01210 R01213 R01256;R01274 R01277 R01280 R01281 R01300 R01301 R01318 R01319;R01322 R01357 R01358 R01368 R01422 R01461 R01496 R01556;R01558 R01598 R01613 R01614 R01615 R01616 R01617 R01624;R01625 R01626 R01651 R01776 R01777 R01798 R01806 R01807;R01808 R01850 R01889 R01923 R01933 R01941 R01943 R01944;R01945 R01946 R01952 R01978 R01999 R02058 R02081 R02082;R02083 R02138 R02152 R02191 R02193 R02194 R02195 R02220;R02221 R02224 R02241 R02242 R02251 R02255 R02366 R02367;R02375 R02385 R02387 R02396 R02402 R02404 R02405 R02406;R02416 R02447 R02450 R02452 R02453 R02481 R02482 R02505;R02506 R02539 R02543 R02569 R02570 R02571 R02576 R02616;R02617 R02620 R02662 R02694 R02699 R02760 R02764 R02772;R02794 R02837 R02899 R02911 R02986 R03017 R03040 R03056;R03064 R03065 R03109 R03157 R03158 R03168 R03171 R03174;R03209 R03210 R03230 R03352 R03374 R03381 R03383 R03437;R03438 R03455 R03552 R03621 R03631 R03668 R03695 R03718;R03719 R03720 R03727 R03735 R03755 R03756 R03760 R03762;R03767 R03778 R03779 R03838 R03858 R03859 R03861 R03903;R03910 R03932 R03965 R03974 R03991 R03992 R03994 R04021;R04022 R04024 R04030 R04050 R04097 R04150 R04157 R04192;R04205 R04211 R04254 R04316 R04348 R04356 R04361 R04363;R04364 R04365 R04413 R04466 R04480 R04484 R04507 R04546;R04580 R04618 R04709 R04723 R04742 R04747 R04776 R04777;R04811 R04868 R04950 R05063 R05064 R05129 R05163 R05188;R05189 R05190 R05330 R05331 R05332 R05351 R05451 R05452;R05455 R05506 R05537 R05546 R05586 R05587 R05620 R05672;R05714 R05744 R05841 R05870 R05876 R05918 R06251 R06307;R06310 R06311 R06361 R06367 R06368 R06396 R06409 R06410;R06414 R06415 R06448 R06453 R06458 R06459 R06480 R06481;R06482 R06483 R06510 R06515 R06517 R06527 R06544 R06545;R06568 R06569 R06583 R06624 R06625 R06635 R06637 R06641;R06643 R06644 R06645 R06731 R06735 R06736 R06796 R06797;R06799 R06800 R06801 R06806 R06817 R06821 R06872 R06908;R06944 R06978 R06987 R06997 R07160 R07161 R07175 R07249;R07250 R07251 R07252 R07253 R07255 R07262 R07294 R07296;R07382 R07399 R07416 R07432 R07433 R07719 R07721 R07731;R07741 R07754 R07757 R07758 R07815 R07828 R07833 R07873;R07876 R07880 R07881 R07882 R07883 R07884 R07885 R07886;R07887 R07891 R07895 R07899 R07902 R07910 R07926 R07927;R07928 R07929 R07930 R07931 R07937 R07938 R07944 R07953;R07987 R07988 R07989 R08036 R08088 R08091 R08095 R08097;R08117 R08171 R08172 R08174 R08175 R08176 R08177 R08178;R08179 R08180 R08181 R08182 R08183 R08184 R08185 R08186;R08187 R08188 R08189 R08190 R08191 R08192 R08213 R08248;R08250 R08273 R08331 R08332 R08381 R08386 R08423 R08430;R08432 R08433 R08453 R08530 R08531 R08532 R08549 R08566;R08567 R08619 R08623 R08627 R08631 R08640 R08644 R08680;R08712 R08713 R08733 R08738 R08743 R08744 R08745 R08767;R08796 R08797 R08805 R08806 R08807 R08808 R08809 R08810;R08870 R08871 R08938 R08983 R09034 R09035 R09036 R09037;R09096 R09097 R09106 R09255 R09256 R09257 R09258 R09279;R09280 R09286 R09317 R09419 R09450 R09470 R09524 R09527;R09528 R09557 R09589 R09621 R09622 R09631 R09643 R09839;R09840 R09842 R09854 R09873 R10003 R10099 R10100 R10104;R10142 R10171 R10172 R10173 R10174 R10200 R10210 R10219;R10233 R10234 R10237 R10238 R10239 R10243 R10253 R10254;R10278 R10473 R10474 R10484 R10485 R10500 R10514 R10516;R10526 R10529 R10589 R10590 R10612 R10681 R10700 R10707;R10745 R10746 R10747 R10758 R10769 R10770 R10771 R10820;R10825 R10866 R10893 R10936 R10947 R10960 R10965 R10967;R10998 R11124 R11125 R11182 R11199 R11200 R11201 R11370;R11390 R11412 R11435 R11445 R11450 R11451 R11479 R11516;R11542 R11550 R11584 R11586 R11588 R11615 R11616 R11632;R11664 R11667 R11701 R11708 R11723 R11781 R11782 R11902;R11926 R11957 R11958 R12039 R12042 R12049 R12085 R12117;R12159,Compounds with biological roles [BR:br08001]; Vitamins and Cofactors;  Cofactors;   Coenzymes;    C00010  CoA,CAS: 85-61-0;PubChem: 3312;ChEBI: 15346;ChEMBL: CHEMBL1213327 CHEMBL1623949;KNApSAcK: C00007258;PDB-CCD: COA;3DMET: B04618;NIKKAJI: J192.630F
C03056,C5H5NO2,111.0987,111.032,Nicotinate and nicotinamide metabolism;Microbial metabolism in diverse environments,"2,6-Dihydroxypyridine",R04130 R07515,R04130 R07515,,CAS: 626-06-2;PubChem: 5956;ChEBI: 17681;ChEMBL: CHEMBL3086507;3DMET: B00531;NIKKAJI: J58.008B
C00179,C5H14N4,130.1915,130.1218,Arginine and proline metabolism;Metabolic pathways,Agmatine;(4-Aminobutyl) guanidine,R00566 R01157 R01416 R01417 R01418 R01425 R01617 R09255;R10338 R10496,R00566 R01157 R01416 R01417 R01418 R01425 R01617 R09255;R10338 R10496,Phytochemical compounds [BR:br08003]; Amino acid related compounds;  Others;   Amines;    C00179  Agmatine;Target-based classification of compounds [BR:br08010]; G Protein-coupled receptors;  Rhodopsin family: amine receptors;   Adrenaline;    alpha2a-adrenergic receptor;     C00179  Agmatine;    alpha2b-adrenergic receptor;     C00179  Agmatine;    alpha2c-adrenergic receptor;     C00179  Agmatine,CAS: 306-60-5;PubChem: 3479;ChEBI: 17431;ChEMBL: CHEMBL58343;KNApSAcK: C00001400;PDB-CCD: AG2;3DMET: B00052;NIKKAJI: J11.608D
C00315,C7H19N3,145.2459,145.1579,Arginine and proline metabolism;beta-Alanine metabolism;Glutathione metabolism;Phenylpropanoid biosynthesis;Metabolic pathways;ABC transporters;Bile secretion,"Spermidine;N-(3-Aminopropyl)-1,4-butane-diamine",R01914 R01915 R01917 R01918 R01919 R01920 R02869 R03899;R05329 R07300 R07477 R08983 R09076 R09077 R09081 R09531;R10347 R11154 R11159 R11199 R11200,R01914 R01915 R01917 R01918 R01919 R01920 R02869 R03899;R05329 R07300 R07477 R08983 R09076 R09077 R09081 R09531;R10347 R11154 R11159 R11199 R11200,,CAS: 124-20-9;PubChem: 3609;ChEBI: 16610;ChEMBL: CHEMBL19612;KNApSAcK: C00001431;PDB-CCD: SPD SR0;3DMET: B01214;NIKKAJI: J10.054D
C00534,C8H12N2O2,168.1931,168.0899,Vitamin B6 metabolism;Metabolic pathways;Microbial metabolism in diverse environments;Vitamin digestion and absorption,Pyridoxamine;PM,R01710 R01712 R01713 R02493 R02494 R05839,R01710 R01712 R01713 R02493 R02494 R05839,Compounds with biological roles [BR:br08001]; Vitamins and Cofactors;  Vitamins;   Water-soluble vitamins;    C00534  Pyridoxamine (Vitamin B6);Risk category of Japanese OTC drugs [BR:br08312]; Third-class OTC drugs;  Inorganic and organic chemicals;   Pyridoxine hydrochloride;    C00534  Pyridoxamine,CAS: 85-87-0;PubChem: 3816;ChEBI: 16410;ChEMBL: CHEMBL593019;KNApSAcK: C00007504;PDB-CCD: PXM;3DMET: B00123;NIKKAJI: J3.891A
C05422,C6H6O6,174.1082,174.0164,Ascorbate and aldarate metabolism;Glutathione metabolism;Metabolic pathways,Dehydroascorbate;Dehydroascorbic acid;L-Dehydroascorbate;L-Dehydroascorbic acid,R00068 R00644 R01108 R02535 R03185 R03186 R03912 R04785;R07178 R07179 R07214 R07679 R08358 R10055 R12144,R00068 R00644 R01108 R02535 R03185 R03186 R03912 R04785;R07178 R07179 R07214 R07679 R08358 R10055 R12144,,CAS: 490-83-5;PubChem: 7786;ChEBI: 27956;KNApSAcK: C00007380;PDB-CCD: UU3;3DMET: B01855;NIKKAJI: J12.580F
C00333,C6H10O7,194.1394,194.0427,Pentose and glucuronate interconversions;Ascorbate and aldarate metabolism;Amino sugar and nucleotide sugar metabolism;Metabolic pathways;ABC transporters,D-Galacturonate;D-Galacturonic acid,R01980 R01981 R01982 R01983 R01984 R04320 R06201 R07413;R07676 R10565 R10841,R01980 R01981 R01982 R01983 R01984 R04320 R06201 R07413;R07676 R10565 R10841,Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Sugar acids;    C00333  D-Galacturonic acid,CAS: 685-73-4;PubChem: 3627;ChEBI: 12952 4153;KNApSAcK: C00001120;PDB-CCD: ADA GTR;3DMET: B04672;NIKKAJI: J82.118G
C19670,C18H35NO,281.4766,281.2719,,Oleamide;Oleyl amide;(Z)-9-Octadecenamide,R09537,R09537,,CAS: 301-02-0;PubChem: 135626138;ChEMBL: CHEMBL15927
C00665,C6H14O12P2,340.1157,339.996,Fructose and mannose metabolism;AMPK signaling pathway;Glucagon signaling pathway;Central carbon metabolism in cancer,"beta-D-Fructose 2,6-bisphosphate;D-Fructose 2,6-bisphosphate",R00763 R02730 R02731 R02732,R00763 R02730 R02731 R02732,,PubChem: 3934;ChEBI: 28602;PDB-CCD: FDP;3DMET: B01302;NIKKAJI: J470.690K
C00440,C20H25N7O6,459.4558,459.1866,One carbon pool by folate;Carbon fixation pathways in prokaryotes;Metabolic pathways;Microbial metabolism in diverse environments;Carbon metabolism;Antifolate resistance,5-Methyltetrahydrofolate,R00946 R01217 R01224 R02289 R02573 R02912 R07168 R09270;R09271 R10136 R10243 R10333,R00946 R01217 R01224 R02289 R02573 R02912 R07168 R09270;R09271 R10136 R10243 R10333,,CAS: 134-35-0;PubChem: 3729;ChEBI: 15641;ChEMBL: CHEMBL1221561 CHEMBL1231574;KNApSAcK: C00007252;PDB-CCD: C2F THH;3DMET: B04681;NIKKAJI: J356.349I
C02612,C5H8O5,148.114,148.0372,"Valine, leucine and isoleucine biosynthesis;C5-Branched dibasic acid metabolism;Metabolic pathways;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids",(R)-2-Methylmalate;(R)-2-Methylmalic acid;(R)-Citramalate;(R)-Citramalic acid;(R)-alpha-Hydroxypyrotartaric acid;D-Citramalate;D-Citramalic acid;D-alpha-Hydroxypyrotartaric acid;(2R)-2-Hydroxy-2-methylbutanedioate,R03896 R03995 R07399 R10640,R03896 R03995 R07399 R10640,,PubChem: 5597;ChEBI: 15586 30934;3DMET: B00465;NIKKAJI: J73.970G
C00415,C19H21N7O6,443.4133,443.1553,One carbon pool by folate;Folate biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Antifolate resistance,"Dihydrofolate;Dihydrofolic acid;7,8-Dihydrofolate;7,8-Dihydrofolic acid;7,8-Dihydropteroylglutamate",R00936 R00939 R01670 R02101 R02235 R02236 R02237 R02238,R00936 R00939 R01670 R02101 R02235 R02236 R02237 R02238,,CAS: 4033-27-6;PubChem: 3705;ChEBI: 15633;ChEMBL: CHEMBL46294;KNApSAcK: C00007248;PDB-CCD: DHF;3DMET: B01240;NIKKAJI: J373.767E
C03722,C7H5NO4,167.1189,167.0219,"Tryptophan metabolism;beta-Alanine metabolism;Nicotinate and nicotinamide metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid;Metabolic pathways","Quinolinate;Pyridine-2,3-dicarboxylate;Quinolinic acid;2,3-Pyridinedicarboxylic acid",R00915 R03348 R04292 R04293,R00915 R03348 R04292 R04293,,CAS: 89-00-9;PubChem: 6487;ChEBI: 16675;ChEMBL: CHEMBL286204;KNApSAcK: C00007381;PDB-CCD: NTM;3DMET: B00627;NIKKAJI: J4.298F
C00341,C10H20O7P2,314.2091,314.0684,Ubiquinone and other terpenoid-quinone biosynthesis;Terpenoid backbone biosynthesis;Monoterpenoid biosynthesis;Biosynthesis of plant secondary metabolites;Biosynthesis of terpenoids and steroids;Biosynthesis of alkaloids derived from terpenoid and polyketide;Biosynthesis of plant hormones;Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of antibiotics,Geranyl diphosphate,R01658 R02003 R02004 R02006 R02007 R02009 R02010 R02011;R02013 R05765 R05766 R06120 R06421 R07631 R07632 R08393;R08394 R08395 R08396 R08397 R08398 R08399 R08528 R09040;R09250 R09940 R09961 R09962 R09963 R09964 R09965 R09966;R09968 R09969 R09970 R09971 R09972 R09974 R09975 R10176;R10509 R10969 R11086 R11087 R11551 R11602 R11603 R11842;R12089,R01658 R02003 R02004 R02006 R02007 R02009 R02010 R02011;R02013 R05765 R05766 R06120 R06421 R07631 R07632 R08393;R08394 R08395 R08396 R08397 R08398 R08399 R08528 R09040;R09250 R09940 R09961 R09962 R09963 R09964 R09965 R09966;R09968 R09969 R09970 R09971 R09972 R09974 R09975 R10176;R10509 R10969 R11086 R11087 R11551 R11602 R11603 R11842;R12089,Lipids [BR:br08002]; PR  Prenol Lipids;  PR01 Isoprenoids;   PR0102 C10 isoprenoids (monoterpenes);    PR010201 Acyclic monoterpenoids;     C00341  Geranyl diphosphate;Phytochemical compounds [BR:br08003]; Terpenoids;  Monoterpenoids (C10);   Linear monoterpenes;    C00341  Geranyl diphosphate,PubChem: 3634;ChEBI: 17211;ChEMBL: CHEMBL41342;LIPIDMAPS: LMPR0102010001;LipidBank: IIP0003;KNApSAcK: C00000846;PDB-CCD: GPP;3DMET: B00091;NIKKAJI: J1.452.575K J39.583H
C00109,C4H6O3,102.0886,102.0317,"Glycine, serine and threonine metabolism;Cysteine and methionine metabolism;Valine, leucine and isoleucine biosynthesis;Propanoate metabolism;C5-Branched dibasic acid metabolism;Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of antibiotics;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids",2-Oxobutanoate;2-Ketobutyric acid;2-Oxobutyric acid;2-Oxobutyrate;2-Oxobutanoic acid;alpha-Ketobutyric acid;alpha-Ketobutyrate,R00654 R00993 R00994 R00995 R00996 R00997 R00998 R00999;R01000 R01001 R01199 R01283 R04673 R04770 R04930 R05840;R06987 R08637 R08648 R10991 R10992 R10996 R11098,R00654 R00993 R00994 R00995 R00996 R00997 R00998 R00999;R01000 R01001 R01199 R01283 R04673 R04770 R04930 R05840;R06987 R08637 R08648 R10991 R10992 R10996 R11098,Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   2-Oxocarboxylic acids;    C00109  2-Oxobutanoate;Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0106 Oxo fatty acids;    C00109  2-Oxobutanoic acid,CAS: 600-18-0;PubChem: 3409;ChEBI: 16763 30831;ChEMBL: CHEMBL171246;LIPIDMAPS: LMFA01060002;LipidBank: DFA0386;KNApSAcK: C00019675;PDB-CCD: 2KT;3DMET: B00028;NIKKAJI: J2.726J
C00108,C7H7NO2,137.136,137.0477,"Tryptophan metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Phenazine biosynthesis;Dioxin degradation;Aminobenzoate degradation;Biosynthesis of secondary metabolites - unclassified;Acridone alkaloid biosynthesis;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of plant hormones;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of antibiotics;Degradation of aromatic compounds;Biosynthesis of amino acids;Benzoic acid family",Anthranilate;Anthranilic acid;o-Aminobenzoic acid;Vitamin L1;2-Aminobenzoate,R00823 R00825 R00980 R00982 R00983 R00984 R00985 R00986;R00987 R00988 R00989 R00990 R00991 R01073 R01816 R02453;R05365 R07734 R08473 R08477 R09517 R10451 R10495 R12035,R00823 R00825 R00980 R00982 R00983 R00984 R00985 R00986;R00987 R00988 R00989 R00990 R00991 R01073 R01816 R02453;R05365 R07734 R08473 R08477 R09517 R10451 R10495 R12035,Carcinogens [BR:br08008]; Group 3: Not classifiable as to its carcinogenicity to humans;  Compounds;   C00108  Anthranilate,CAS: 118-92-3;PubChem: 3408;ChEBI: 16567 30754;ChEMBL: CHEMBL14173;KNApSAcK: C00007382;PDB-CCD: BE2;3DMET: B00027;NIKKAJI: J2.912B
C16656,C8H12O2,140.1797,140.0837,Drug metabolism - cytochrome P450,"2-Propyl-2,4-pentadienoic acid;2,4-Diene-VPA",R08329,R08329,"Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0102 Branched fatty acids;    C16656  2-Propyl-2,4-pentadienoic acid",CAS: 72010-18-5;PubChem: 51090980;ChEBI: 80642;ChEMBL: CHEMBL3706507;NIKKAJI: J391.097K
C03758,C8H11NO2,153.1784,153.079,Tyrosine metabolism;Isoquinoline alkaloid biosynthesis;Betalain biosynthesis;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Metabolic pathways;Biosynthesis of secondary metabolites;cAMP signaling pathway;Neuroactive ligand-receptor interaction;Gap junction;Synaptic vesicle cycle;Dopaminergic synapse;Prolactin signaling pathway;Bile secretion;Parkinson disease;Cocaine addiction;Amphetamine addiction;Morphine addiction;Alcoholism,"Dopamine;4-(2-Aminoethyl)-1,2-benzenediol;4-(2-Aminoethyl)benzene-1,2-diol;3,4-Dihydroxyphenethylamine;2-(3,4-Dihydroxyphenyl)ethylamine",R02080 R02383 R02535 R04084 R04300 R04301 R04305 R05749;R05750 R08444 R08445 R08447 R08513 R08832 R08835 R11684,R02080 R02383 R02535 R04084 R04300 R04301 R04305 R05749;R05750 R08444 R08445 R08447 R08513 R08832 R08835 R11684,Compounds with biological roles [BR:br08001]; Peptides;  Amines;   Biogenic amines;    C03758  Dopamine; Hormones and transmitters;  Other hormones;   Dopamine;    C03758  Dopamine;  Neurotransmitters;   Biogenic amines;    C03758  Dopamine;Phytochemical compounds [BR:br08003]; Alkaloids;  Alkaloids derived from tyrosine;   Tyramine derivatives;    C03758  Dopamine;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; C CARDIOVASCULAR SYSTEM;  C01 CARDIAC THERAPY;   C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;    C01CA Adrenergic and dopaminergic agents;     C01CA04 Dopamine;      D07870  Dopamine (INN);Target-based classification of drugs [BR:br08310]; G Protein-coupled receptors;  Rhodopsin family;   Dopamine;    DRD;     D07870  Dopamine (INN);Prodrugs [br08324.html]; D07870,CAS: 51-61-6;PubChem: 6517;ChEBI: 18243;ChEMBL: CHEMBL59;KNApSAcK: C00001408;PDB-CCD: LDP;3DMET: B00634;NIKKAJI: J4.120C
C05582,C9H10O4,182.1733,182.0579,Tyrosine metabolism;Metabolic pathways;Dopaminergic synapse,Homovanillate;Homovanillic acid;3-Methoxy-4-hydroxyphenylacetate,R03304 R04888 R04889,R03304 R04888 R04889,,CAS: 306-08-1;PubChem: 7908;ChEBI: 545959;ChEMBL: CHEMBL1562;KNApSAcK: C00029504;PDB-CCD: YTX;3DMET: B00798;NIKKAJI: J61.262F
C00197,C3H7O7P,186.0572,185.9929,"Glycolysis / Gluconeogenesis;Pentose phosphate pathway;Glycine, serine and threonine metabolism;Glycerolipid metabolism;Glyoxylate and dicarboxylate metabolism;Methane metabolism;Carbon fixation in photosynthetic organisms;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of terpenoids and steroids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid;Biosynthesis of alkaloids derived from histidine and purine;Biosynthesis of alkaloids derived from terpenoid and polyketide;Biosynthesis of plant hormones;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of antibiotics;Carbon metabolism;Biosynthesis of amino acids;Glucagon signaling pathway;Central carbon metabolism in cancer",3-Phospho-D-glycerate;D-Glycerate 3-phosphate;3-Phospho-(R)-glycerate;3-Phosphoglycerate,R00024 R01058 R01511 R01512 R01513 R01514 R01515 R01516;R01517 R01518 R01660 R02188 R03140 R05768 R07159 R08887;R09100 R09663 R10860,R00024 R01058 R01511 R01512 R01513 R01514 R01515 R01516;R01517 R01518 R01660 R02188 R03140 R05768 R07159 R08887;R09100 R09663 R10860,,PubChem: 3497;ChEBI: 17794;ChEMBL: CHEMBL1160563;KNApSAcK: C00019551;PDB-CCD: 3PG;3DMET: B01185;NIKKAJI: J40.061K
C01132,C8H15NO6,221.2078,221.0899,Galactose metabolism;Phosphotransferase system (PTS),N-Acetyl-D-galactosamine;N-Acetyl-D-chondrosamine;2-Acetamido-2-deoxy-D-galactose,R03492 R04183 R04184 R04586 R05963 R05966 R06001 R06004;R08366 R08967,R03492 R04183 R04184 R04586 R05963 R05966 R06001 R06004;R08366 R08967,Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Amino sugars;    C01132  N-Acetyl-D-galactosamine,CAS: 14215-68-0 1811-31-0;PubChem: 4363;ChEBI: 28037;ChEMBL: CHEMBL39064 CHEMBL469447;PDB-CCD: A2G NGA;3DMET: B04773;NIKKAJI: J199.634G J382.936G
C06424,C14H28O2,228.3709,228.2089,Fatty acid biosynthesis;Metabolic pathways,Tetradecanoic acid;Tetradecanoate;Myristic acid,R08159,R08159,Compounds with biological roles [BR:br08001]; Lipids;  Fatty acids;   Saturated fatty acids;    C06424  Myristic acid (14:0);Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0101 Straight chain fatty acids;    C06424  Tetradecanoic acid;Phytochemical compounds [BR:br08003]; Fatty acids related compounds;  Fatty acids;   Saturated fatty acids;    C06424  Myristic acid;Pharmaceutical additives in Japan [BR:br08316]; Base;  C06424  [104368] Myristic acid,CAS: 544-63-8;PubChem: 8659;ChEBI: 28875 30807;ChEMBL: CHEMBL111077;LIPIDMAPS: LMFA01010014;LipidBank: DFA0014;KNApSAcK: C00001228;PDB-CCD: MYR;3DMET: B02019;NIKKAJI: J4.411C
C06425,C20H40O2,312.5304,312.3028,Biosynthesis of unsaturated fatty acids,Icosanoic acid;Eicosanoic acid;Arachidic acid,R08175,R08175,Compounds with biological roles [BR:br08001]; Lipids;  Fatty acids;   Saturated fatty acids;    C06425  Arachidic acid (20:0);Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0101 Straight chain fatty acids;    C06425  Icosanoic acid;Phytochemical compounds [BR:br08003]; Fatty acids related compounds;  Fatty acids;   Saturated fatty acids;    C06425  Arachidic acid,CAS: 506-30-9;PubChem: 8660;ChEBI: 28822;ChEMBL: CHEMBL1173381;LIPIDMAPS: LMFA01010020;LipidBank: DFA0020;KNApSAcK: C00001209;PDB-CCD: DCR;3DMET: B02020;NIKKAJI: J2.607G
C08262,C5H10O2,102.1317,102.0681,Biosynthesis of alkaloids derived from histidine and purine;Biosynthesis of secondary metabolites;Protein digestion and absorption,3-Methylbutanoic acid;Isovaleric acid;Isovalerate,R08411 R08412,R08411 R08412,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0102 Branched fatty acids;    C08262  3-Methylbutanoic acid,CAS: 503-74-2;PubChem: 10461;ChEBI: 28484;ChEMBL: CHEMBL568737;LIPIDMAPS: LMFA01020181;LipidBank: DFA0226;KNApSAcK: C00001189 C00033067;PDB-CCD: IVA;3DMET: B02153;NIKKAJI: J2.605K
C03088,C5H6N2O3,142.1127,142.0378,,5-Hydroxymethyluracil,R01412 R08610,R01412 R08610,,CAS: 4433-40-3;PubChem: 5986;ChEBI: 16964;ChEMBL: CHEMBL1233360;PDB-CCD: HMU;3DMET: B00540;NIKKAJI: J58.058I
C02953,C9H13N5O3,239.2312,239.1018,Folate biosynthesis;Metabolic pathways,"7,8-Dihydrobiopterin;L-erythro-7,8-Dihydrobiopterin",R02975 R11765 R11767,R02975 R11765 R11767,,CAS: 6779-87-9;PubChem: 5871;ChEBI: 64277;PDB-CCD: HBI;NIKKAJI: J959.455H
C00345,C6H13O10P,276.1352,276.0246,Pentose phosphate pathway;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of antibiotics;Carbon metabolism,6-Phospho-D-gluconate,R01528 R01737 R02032 R02034 R02035 R02036 R10221,R01528 R01737 R02032 R02034 R02035 R02036 R10221,,PubChem: 3638;ChEBI: 48928;ChEMBL: CHEMBL1230513;KNApSAcK: C00007481;PDB-CCD: 6PG;3DMET: B01221;NIKKAJI: J1.343.743B
C00431,C5H11NO2,117.1463,117.079,Lysine degradation;Arginine and proline metabolism,5-Aminopentanoate;5-Aminopentanoic acid;5-Aminovaleric acid,R02273 R02274 R02276 R02825 R12215,R02273 R02274 R02276 R02825 R12215,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0110 Amino fatty acids;    C00431  5-Aminopentanoic acid,CAS: 660-88-8;PubChem: 3720;ChEBI: 15887;ChEMBL: CHEMBL284116;LIPIDMAPS: LMFA01100040;PDB-CCD: DAV;3DMET: B00111;NIKKAJI: J38.132B
C00263,C4H9NO3,119.1192,119.0582,"Glycine, serine and threonine metabolism;Cysteine and methionine metabolism;Lysine biosynthesis;Sulfur metabolism;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of antibiotics;Biosynthesis of amino acids",L-Homoserine;2-Amino-4-hydroxybutyric acid,R00175 R01771 R01773 R01775 R01776 R01777,R00175 R01771 R01773 R01775 R01776 R01777,Compounds with biological roles [BR:br08001]; Peptides;  Amino acids;   Other amino acids;    C00263  L-Homoserine,CAS: 672-15-1;PubChem: 3561;ChEBI: 15699;ChEMBL: CHEMBL11722;KNApSAcK: C00001366;PDB-CCD: HSE;3DMET: B01202;NIKKAJI: J9.199E
C17714,C7H14O2,130.1849,130.0994,,Heptanoic acid,,,Compounds with biological roles [BR:br08001]; Organic acids;  Carboxylic acids;   Monocarboxylic acids;    C17714  Enanthate; Heptanoate;Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0101 Straight chain fatty acids;    C17714  Heptanoic acid,CAS: 111-14-8;PubChem: 96024044;ChEBI: 45571;ChEMBL: CHEMBL320358;PDB-CCD: SHV;NIKKAJI: J1.985B
C00430,C5H9NO3,131.1299,131.0582,"Glycine, serine and threonine metabolism;Porphyrin and chlorophyll metabolism;Biosynthesis of plant secondary metabolites;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;ABC transporters",5-Aminolevulinate;5-Amino-4-oxopentanoate;5-Amino-4-oxovaleric acid,R00036 R00830 R02271 R02272,R00036 R00830 R02271 R02272,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS;  L01 ANTINEOPLASTIC AGENTS;   L01X OTHER ANTINEOPLASTIC AGENTS;    L01XD Sensitizers used in photodynamic/radiation therapy;     L01XD04 Aminolevulinic acid;      D07567  Aminolevulinic acid,CAS: 106-60-5;PubChem: 3719;ChEBI: 17549;ChEMBL: CHEMBL601;KNApSAcK: C00007378;3DMET: B00110;NIKKAJI: J38.537I
C03440,C5H9NO3,131.1299,131.0582,Arginine and proline metabolism,cis-4-Hydroxy-D-proline,R03296 R04221 R11428,R03296 R04221 R11428,,CAS: 2584-71-6;PubChem: 6264;ChEBI: 16231;ChEMBL: CHEMBL1229563;3DMET: B01659;NIKKAJI: J192.095B
C00979,C5H9NO4,147.1293,147.0532,Cysteine and methionine metabolism;Zeatin biosynthesis;Sulfur metabolism;Biosynthesis of secondary metabolites - unclassified;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of antibiotics;Carbon metabolism;Biosynthesis of amino acids;Sulfur relay system,O-Acetyl-L-serine;O3-Acetyl-L-serine,R00586 R00897 R03131 R03132 R03133 R03134 R03601 R04091;R04859 R10305 R10461 R10839 R10840,R00586 R00897 R03131 R03132 R03133 R03134 R03601 R04091;R04859 R10305 R10461 R10839 R10840,,CAS: 5147-00-2;PubChem: 4228;ChEBI: 17981;KNApSAcK: C00007459;PDB-CCD: OAS;3DMET: B00213;NIKKAJI: J37.500D
C01601,C9H18O2,158.238,158.1307,,Nonanoic acid;Nonanoate;Pelargonic acid,,,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0101 Straight chain fatty acids;    C01601  Nonanoic acid,CAS: 112-05-0;PubChem: 4755;ChEBI: 29019;ChEMBL: CHEMBL108436;LIPIDMAPS: LMFA01010009;LipidBank: DFA0009;KNApSAcK: C00030829;PDB-CCD: KNA;3DMET: B01467;NIKKAJI: J1.991G
C00637,C10H9NO,159.1846,159.0684,Tryptophan metabolism;Metabolic pathways,Indole-3-acetaldehyde;2-(Indol-3-yl)acetaldehyde;Indoleacetaldehyde,R01974 R02173 R02678 R02679 R02680 R02681 R08606,R01974 R02173 R02678 R02679 R02680 R02681 R08606,,CAS: 2591-98-2;PubChem: 3910;ChEBI: 18086;KNApSAcK: C00000109;3DMET: B00152;NIKKAJI: J398.271H
C02979,C3H9O6P,172.0737,172.0137,,Glycerol 2-phosphate;beta-Glycerophosphoric acid,R01043,R01043,,CAS: 17181-54-3;PubChem: 5889;ChEBI: 17270;ChEMBL: CHEMBL1232903;KNApSAcK: C00007407;PDB-CCD: G2H;3DMET: B00522;NIKKAJI: J135.242C
C00392,C6H14O6,182.1718,182.079,Fructose and mannose metabolism;ABC transporters;Phosphotransferase system (PTS),Mannitol;D-Mannitol,R00865 R00868 R00870 R02167 R02704 R05698 R07135,R00865 R00868 R00870 R02167 R02704 R05698 R07135,"Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Sugar alcohols;    C00392  Mannitol;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; A ALIMENTARY TRACT AND METABOLISM;  A06 DRUGS FOR CONSTIPATION;   A06A DRUGS FOR CONSTIPATION;    A06AD Osmotically acting laxatives;     A06AD16 Mannitol;      D00062  Mannitol (USP) &lt;JP/US&gt;; B BLOOD AND BLOOD FORMING ORGANS;  B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;   B05B I.V. SOLUTIONS;    B05BC Solutions producing osmotic diuresis;     B05BC01 Mannitol;      D00062  Mannitol (USP) &lt;JP/US&gt;;   B05C IRRIGATING SOLUTIONS;    B05CX Other irrigating solutions;     B05CX04 Mannitol;      D00062  Mannitol (USP) &lt;JP/US&gt;; R RESPIRATORY SYSTEM;  R05 COUGH AND COLD PREPARATIONS;   R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS;    R05CB Mucolytics;     R05CB16 Mannitol;      D00062  Mannitol (USP) &lt;JP/US&gt;;Therapeutic category of drugs in Japan [BR:br08301]; 2  Agents affecting individual organs;  21  Cardiovascular agents;   219  Miscellaneous;    2190  Miscellaneous;     D00062  Mannitol (USP); D-Mannitol (JP17);Pharmaceutical additives in Japan [BR:br08316]; Stabilizing agent;  D00062  [009007] D-Mannitol; Solubilizing agent;  D00062  [009007] D-Mannitol; Sweetening agent;  D00062  [009007] D-Mannitol; Base;  D00062  [009007] D-Mannitol; Flavoring substance;  D00062  [009007] D-Mannitol; Bonding agent;  D00062  [009007] D-Mannitol; Suspending agent;  D00062  [009007] D-Mannitol; Coating agent;  D00062  [009007] D-Mannitol; Sugarcoated agent;  D00062  [009007] D-Mannitol; Tonicity agent;  D00062  [009007] D-Mannitol; Diluting agent;  D00062  [009007] D-Mannitol; Disintegrant;  D00062  [009007] D-Mannitol; Solubilization agent;  D00062  [009007] D-Mannitol;Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D00062  D-Mannitol;  D00062  D-Mannitol injection;New drug approvals in Europe [br08329.html]; European public assessment reports (EPAR) authorised medicine;  D00062",CAS: 69-65-8;PubChem: 3682;ChEBI: 16899;ChEMBL: CHEMBL689;KNApSAcK: C00001165;PDB-CCD: MTL;3DMET: B04676;NIKKAJI: J2.369H
C00794,C6H14O6,182.1718,182.079,Fructose and mannose metabolism;Galactose metabolism;Metabolic pathways;ABC transporters;Phosphotransferase system (PTS),D-Sorbitol;D-Glucitol;L-Gulitol;Sorbitol,R00874 R00875 R01697 R01787 R02865 R02866 R02867 R02868;R02925 R02926 R05820 R07346 R11620,R00874 R00875 R01697 R01787 R02865 R02866 R02867 R02868;R02925 R02926 R05820 R07346 R11620,Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Sugar alcohols;    C00794  Sorbitol;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; A ALIMENTARY TRACT AND METABOLISM;  A06 DRUGS FOR CONSTIPATION;   A06A DRUGS FOR CONSTIPATION;    A06AD Osmotically acting laxatives;     A06AD18 Sorbitol;      D00096  D-Sorbitol (JP17) &lt;JP/US&gt;;    A06AG Enemas;     A06AG07 Sorbitol;      D00096  D-Sorbitol (JP17) &lt;JP/US&gt;; B BLOOD AND BLOOD FORMING ORGANS;  B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS;   B05C IRRIGATING SOLUTIONS;    B05CX Other irrigating solutions;     B05CX02 Sorbitol;      D00096  D-Sorbitol (JP17) &lt;JP/US&gt;; V VARIOUS;  V04 DIAGNOSTIC AGENTS;   V04C OTHER DIAGNOSTIC AGENTS;    V04CC Tests for bile duct patency;     V04CC01 Sorbitol;      D00096  D-Sorbitol (JP17) &lt;JP/US&gt;;Therapeutic category of drugs in Japan [BR:br08301]; 2  Agents affecting individual organs;  25  Urogenital and anal organ agents;   251  Urinary organ agents;    2519  Others;     D00096  D-Sorbitol (JP17); Sorbitol (NF); 7  Agents not mainly for therapeutic purpose;  79  Other agents not mainly for therapeutic purpose;   799  Miscellaneous;    7990  Miscellaneous;     D00096  D-Sorbitol (JP17); Sorbitol (NF);Risk category of Japanese OTC drugs [BR:br08312]; Third-class OTC drugs;  Inorganic and organic chemicals;   D-Sorbitol;    D00096  D-Sorbitol (JP17);Pharmaceutical additives in Japan [BR:br08316]; Stabilizing agent;  D00096  [002244] D-Sorbitol;  D00096  [002245] D-Sorbitol solution; Plasticizer;  D00096  [002244] D-Sorbitol; Sweetening agent;  D00096  [002244] D-Sorbitol;  D00096  [002245] D-Sorbitol solution; Base;  D00096  [002244] D-Sorbitol;  D00096  [002245] D-Sorbitol solution; Flavoring substance;  D00096  [002244] D-Sorbitol;  D00096  [002245] D-Sorbitol solution; Bonding agent;  D00096  [002244] D-Sorbitol; Suspending agent;  D00096  [002244] D-Sorbitol; Coating agent;  D00096  [002244] D-Sorbitol;  D00096  [002245] D-Sorbitol solution; Film;  D00096  [002244] D-Sorbitol; Wetting agent;  D00096  [002244] D-Sorbitol;  D00096  [002245] D-Sorbitol solution; Tonicity agent;  D00096  [002244] D-Sorbitol;  D00096  [002245] D-Sorbitol solution; Emulsion;  D00096  [002244] D-Sorbitol; Tenacious agent;  D00096  [002245] D-Sorbitol solution; Diluting agent;  D00096  [002244] D-Sorbitol;  D00096  [002245] D-Sorbitol solution; Dispersant;  D00096  [002244] D-Sorbitol; Preserving agent;  D00096  [002244] D-Sorbitol; Solubilization agent;  D00096  [002244] D-Sorbitol;  D00096  [002245] D-Sorbitol solution;Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D00096  D-Sorbitol;  D00096  D-Sorbitol solution;Drug classes of therapeutic agents [br08360.html]; Gastrointestinal agents;  D00096,CAS: 50-70-4;PubChem: 4052;ChEBI: 17924;ChEMBL: CHEMBL1682;KNApSAcK: C00001173;PDB-CCD: SOR;3DMET: B04724;NIKKAJI: J2.299C
C08261,C9H16O4,188.2209,188.1049,,"Azelaic acid;Nonanedioic acid;1,7-Heptanedicarboxylic acid",,,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0117 Dicarboxylic acids;    C08261  Nonanedioic acid;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; D DERMATOLOGICALS;  D10 ANTI-ACNE PREPARATIONS;   D10A ANTI-ACNE PREPARATIONS FOR TOPICAL USE;    D10AX Other anti-acne preparations for topical use;     D10AX03 Azelaic acid;      D03034  Azelaic acid (USAN/INN) &lt;US&gt;;USP drug classification [BR:br08302]; Dermatological Agents;  Azelaic acid;   D03034  Azelaic acid (USAN/INN),CAS: 123-99-9;PubChem: 10460;ChEBI: 48131;ChEMBL: CHEMBL1238;LIPIDMAPS: LMFA01170054;KNApSAcK: C00045634;PDB-CCD: AZ1;3DMET: B02152;NIKKAJI: J10.058G
C00103,C6H13O9P,260.1358,260.0297,Glycolysis / Gluconeogenesis;Pentose and glucuronate interconversions;Galactose metabolism;Starch and sucrose metabolism;Amino sugar and nucleotide sugar metabolism;Streptomycin biosynthesis;Polyketide sugar unit biosynthesis;Acarbose and validamycin biosynthesis;Glycerolipid metabolism;Biosynthesis of plant secondary metabolites;Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of antibiotics;Glucagon signaling pathway,D-Glucose 1-phosphate;alpha-D-Glucose 1-phosphate;Cori ester;D-Glucose alpha-1-phosphate,R00287 R00289 R00304 R00550 R00803 R00947 R00948 R00949;R00951 R00952 R00953 R00954 R00955 R00956 R00957 R00959;R00960 R01233 R01660 R01821 R02111 R02328 R02888 R03116;R04180 R05512 R06018 R06022 R06034 R06050 R06056 R06058;R06061 R06185 R07265 R08514 R08515 R08639 R09752 R10832;R10987 R11128 R11530 R11959,R00287 R00289 R00304 R00550 R00803 R00947 R00948 R00949;R00951 R00952 R00953 R00954 R00955 R00956 R00957 R00959;R00960 R01233 R01660 R01821 R02111 R02328 R02888 R03116;R04180 R05512 R06018 R06022 R06034 R06050 R06056 R06058;R06061 R06185 R07265 R08514 R08515 R08639 R09752 R10832;R10987 R11128 R11530 R11959,,CAS: 59-56-3;PubChem: 3403;ChEBI: 29042;KNApSAcK: C00007482;PDB-CCD: G1P;3DMET: B04634;NIKKAJI: J40.065C
C12270,C11H16N2O8,304.2533,304.0907,"Alanine, aspartate and glutamate metabolism;Metabolic pathways;Neuroactive ligand-receptor interaction",N-Acetylaspartylglutamate;NAAG;Isospaglumic acid;N-Acetyl-L-aspartyl-L-glutamate,R10678 R10687 R10688 R10693,R10678 R10687 R10688 R10693,,CAS: 3106-85-2;PubChem: 14415;ChEBI: 73688;ChEMBL: CHEMBL1329032;NIKKAJI: J22.752H
C00360,C10H14N5O6P,331.2218,331.0682,Purine metabolism;Metabolic pathways,dAMP;2'-Deoxyadenosine 5'-phosphate;2'-Deoxyadenosine 5'-monophosphate;Deoxyadenylic acid;Deoxyadenosine monophosphate,R01547 R02088 R02089,R01547 R02088 R02089,Compounds with biological roles [BR:br08001]; Nucleic acids;  Nucleotides;   Deoxyribonucleotides;    C00360  dAMP,CAS: 653-63-4;PubChem: 3651;ChEBI: 17713;ChEMBL: CHEMBL1206239;PDB-CCD: D5M DA;3DMET: B01226;NIKKAJI: J205.943F
C08316,C22H42O2,338.5677,338.3185,Biosynthesis of unsaturated fatty acids,Erucic acid;(13Z)-Docosenoic acid;cis-13-Docosenoic acid,R08187,R08187,Compounds with biological roles [BR:br08001]; Lipids;  Fatty acids;   Unsaturated fatty acids;    C08316  Erucic acid (22:1;13);Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0103 Unsaturated fatty acids;    Monounsaturated fatty acids;     C08316  (Z)-Docos-13-enoic acid;Phytochemical compounds [BR:br08003]; Fatty acids related compounds;  Fatty acids;   Unsaturated fatty acids;    C08316  Erucic acid,CAS: 112-86-7;PubChem: 10514;ChEBI: 28792;ChEMBL: CHEMBL1173380;LIPIDMAPS: LMFA01030089 LMFA01030090;LipidBank: DFA0128;KNApSAcK: C00001217;3DMET: B02160;NIKKAJI: J10.102H
C08323,C24H46O2,366.6208,366.3498,Biosynthesis of unsaturated fatty acids,(15Z)-Tetracosenoic acid;Nervonic acid;(Z)-15-Tetracosenoic acid,R08188,R08188,Compounds with biological roles [BR:br08001]; Lipids;  Fatty acids;   Unsaturated fatty acids;    C08323  Nervonic acid (24:1;15);Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0103 Unsaturated fatty acids;    Monounsaturated fatty acids;     C08323  (Z)-Tetracos-15-enoic acid,CAS: 506-37-6;PubChem: 10521;ChEBI: 44247;ChEMBL: CHEMBL1173379;LIPIDMAPS: LMFA01030092;LipidBank: DFA0131;KNApSAcK: C00001230;PDB-CCD: NER;3DMET: B02167;NIKKAJI: J11.357C
C00361,C10H15N5O10P2,427.2011,427.0294,Purine metabolism;Metabolic pathways,dGDP;2'-Deoxyguanosine 5'-diphosphate,R01857 R01858 R01880 R02019 R02090 R02091,R01857 R01858 R01880 R02019 R02090 R02091,Compounds with biological roles [BR:br08001]; Nucleic acids;  Nucleotides;   Deoxyribonucleotides;    C00361  dGDP,PubChem: 3652;ChEBI: 28862;ChEMBL: CHEMBL1232205;PDB-CCD: DGI;3DMET: B01227;NIKKAJI: J366.498H
C13050,C15H21N5O13P2,541.3005,541.0611,Calcium signaling pathway;Oxytocin signaling pathway;Salivary secretion;Pancreatic secretion,Cyclic ADP-ribose;cADPR,R10629 R10630,R10629 R10630,,CAS: 119340-53-3;PubChem: 583439;ChEBI: 31445;ChEMBL: CHEMBL2369151;NIKKAJI: J626.674F
C01026,C4H9NO2,103.1198,103.0633,"Glycine, serine and threonine metabolism;Metabolic pathways","N,N-Dimethylglycine;Dimethylglycine",R01564 R01565 R02821 R07243 R07244 R10060,R01564 R01565 R02821 R07243 R07244 R10060,,CAS: 1118-68-9;PubChem: 4271;ChEBI: 17724;PDB-CCD: DMG;3DMET: B00224;NIKKAJI: J135.420E
C06772,C4H11NO2,105.1356,105.079,Glycerophospholipid metabolism,Diethanolamine,R05381 R05382,R05381 R05382,Carcinogens [BR:br08008]; Group 2B: Possibly carcinogenic to humans;  Compounds;   C06772  Diethanolamine;Pharmaceutical additives in Japan [BR:br08316]; Stabilizing agent;  D02337  [101808] Diethanolamine; Buffering agent;  D02337  [101808] Diethanolamine; Solubilization agent;  D02337  [101808] Diethanolamine,CAS: 111-42-2;PubChem: 8992;ChEBI: 28123;ChEMBL: CHEMBL119604;3DMET: B01050;NIKKAJI: J808G
C00408,C6H11NO2,129.157,129.079,"Lysine degradation;Tropane, piperidine and pyridine alkaloid biosynthesis;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from ornithine, lysine and nicotinic acid;Metabolic pathways;Biosynthesis of secondary metabolites",L-Pipecolate;Pipecolinic acid;Pipecolic acid;2-Piperidinecarboxylic acid;(S)-Piperidine-2-carboxylic acid,R00459 R02201 R02203 R02204 R02205 R02206 R08414 R08415;R09680 R10277,R00459 R02201 R02203 R02204 R02205 R02206 R08414 R08415;R09680 R10277,Phytochemical compounds [BR:br08003]; Alkaloids;  Alkaloids derived from lysine;   Piperidine alkaloids;    C00408  L-Pipecolate,CAS: 3105-95-1;PubChem: 3698;ChEBI: 30633 30913;ChEMBL: CHEMBL322883;KNApSAcK: C00000210 C00001387;PDB-CCD: YCP;3DMET: B01237;NIKKAJI: J215.717I
C02714,C6H14N2O,130.1882,130.1106,Arginine and proline metabolism;Metabolic pathways,N-Acetylputrescine,R01154 R01156 R04025,R01154 R01156 R04025,,CAS: 5699-41-2;PubChem: 5677;ChEBI: 17768;ChEMBL: CHEMBL81241;3DMET: B01596;NIKKAJI: J367.698F
C01996,C7H16NO2,146.2074,146.1181,Glycerophospholipid metabolism;cAMP signaling pathway;Neuroactive ligand-receptor interaction;Synaptic vesicle cycle;Cholinergic synapse;Taste transduction;Regulation of actin cytoskeleton;Insulin secretion;Salivary secretion;Gastric acid secretion;Pancreatic secretion;Bile secretion;Nicotine addiction,Acetylcholine;O-Acetylcholine,R01023 R01026,R01023 R01026,Compounds with biological roles [BR:br08001]; Hormones and transmitters;  Neurotransmitters;   Acetylcholine;    C01996  Acetylcholine;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; S SENSORY ORGANS;  S01 OPHTHALMOLOGICALS;   S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS;    S01EB Parasympathomimetics;     S01EB09 Acetylcholine;      C01996  Acetylcholine,CAS: 51-84-3;PubChem: 5093;ChEBI: 15355;ChEMBL: CHEMBL667;PDB-CCD: ACH;3DMET: B00379;NIKKAJI: J4.127K
C04227,C8H11NO2,153.1784,153.079,Neuroactive ligand-receptor interaction,Octopamine;1-(4-Hydroxyphenyl)-2-aminoethanol;p-Hydroxyphenylethanolamine,R03358,R03358,Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; C CARDIOVASCULAR SYSTEM;  C01 CARDIAC THERAPY;   C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES;    C01CA Adrenergic and dopaminergic agents;     C01CA18 Octopamine;      C04227  Octopamine,CAS: 104-14-3;PubChem: 6898;ChEBI: 17134 44715;ChEMBL: CHEMBL1160703;KNApSAcK: C00001425;PDB-CCD: OTR;NIKKAJI: J5.024E
C00836,C18H39NO2,301.5078,301.2981,Sphingolipid metabolism;Metabolic pathways;Sphingolipid signaling pathway,"Sphinganine;Dihydrosphingosine;2-Amino-1,3-dihydroxyoctadecane",R02976 R02978 R02979 R06517 R06518 R06520 R06525,R02976 R02978 R02979 R06517 R06518 R06520 R06525,Lipids [BR:br08002]; SP  Sphingolipids;  SP01 Sphingoid bases;   SP0102 Sphinganines;    C00836  Sphinganine,CAS: 764-22-7;PubChem: 4094;ChEBI: 16566;ChEMBL: CHEMBL448741;LIPIDMAPS: LMSP01020001;LipidBank: DLB0010;KNApSAcK: C00007540;3DMET: B04734;NIKKAJI: J14.383I
C02630,C5H8O5,148.114,148.0372,Butanoate metabolism;C5-Branched dibasic acid metabolism,2-Hydroxyglutarate;alpha-Hydroxyglutarate,R00932 R03534 R04000 R08198,R00932 R03534 R04000 R08198,,CAS: 2889-31-8;PubChem: 5610;ChEBI: 17084;LIPIDMAPS: LMFA01050483;3DMET: B00467;NIKKAJI: J527.822H
C02774,C10H20O3,188.264,188.1412,,10-Hydroxydecanoic acid;10-Hydroxydecanoate,R03886,R03886,Lipids [BR:br08002]; FA  Fatty acyls;  FA01 Fatty Acids and Conjugates;   FA0105 Hydroxy fatty acids;    C02774  4-Hydroxybutanoic acid;    C02774  10-Hydroxydecanoic acid,CAS: 1679-53-4;PubChem: 5726;ChEBI: 17409;LipidBank: DFA0299;3DMET: B01599;NIKKAJI: J195.322B
C04083,C10H13N5,203.2437,203.1171,Zeatin biosynthesis;Biosynthesis of secondary metabolites;Plant hormone signal transduction,"N6-(Delta2-Isopentenyl)-adenine;N6-(3-Methylbut-2-enyl)adenine;6-(gamma,gamma-Dimethylallylamino)purine;N6-Dimethylallyladenine",R03726 R05708 R08068 R08072,R03726 R05708 R08068 R08072,Pesticides [BR:br08007]; Pesticides;  Plant growth regulators;   Cytokinins;    C04083  N6-(delta2-Isopentenyl)-adenine,CAS: 2365-40-4;PubChem: 6776;ChEBI: 17660;ChEMBL: CHEMBL476189;KNApSAcK: C00000094;PDB-CCD: ZIP;3DMET: B01716;NIKKAJI: J120.788A
C11512,C13H20O3,224.2961,224.1412,alpha-Linolenic acid metabolism;Biosynthesis of secondary metabolites,Methyl jasmonate;(-)-Methyl jasmonate,R05759,R05759,Lipids [BR:br08002]; FA  Fatty acyls;  FA02 Octadecanoids;   FA0202 jasmonic acids;    C11512  Methyl jasmonate,CAS: 1211-29-6;PubChem: 13682;ChEBI: 15929;ChEMBL: CHEMBL2139332;LIPIDMAPS: LMFA02020010;KNApSAcK: C00000219;3DMET: B04270;NIKKAJI: J128.619F
C02721,C4H9NO2,103.1198,103.0633,,N-Methyl-L-alanine,R01584,R01584,,CAS: 3913-67-5;PubChem: 5683;ChEBI: 17519;ChEMBL: CHEMBL1234201;PDB-CCD: MAA;NIKKAJI: J130.628F
C01035,C5H11N3O2,145.1597,145.0851,Arginine and proline metabolism;Metabolic pathways,4-Guanidinobutanoate;4-Guanidinobutyric acid,R01989 R01990 R03177 R03180,R01989 R01990 R03177 R03180,,PubChem: 4278;ChEBI: 15728;ChEMBL: CHEMBL21157;PDB-CCD: ALG;3DMET: B00225;NIKKAJI: J196.182I
C03404,C10H13NO3,195.2151,195.0895,,L-Tyrosine methyl ester,R04213,R04213,,CAS: 1080-06-4;PubChem: 6233;ChEBI: 17215;ChEMBL: CHEMBL300797;NIKKAJI: J5.190J
C00645,C8H15NO6,221.2078,221.0899,Amino sugar and nucleotide sugar metabolism;Metabolic pathways,N-Acetyl-D-mannosamine;2-Acetamido-2-deoxy-D-mannose,R00414 R01207 R01804 R01811 R02705 R02706 R02707,R00414 R01207 R01804 R01811 R02705 R02706 R02707,Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Amino sugars;    C00645  N-Acetyl-D-mannosamine,CAS: 3615-17-6;PubChem: 3918;ChEBI: 17122 63153;ChEMBL: CHEMBL1231391;KNApSAcK: C00019583;PDB-CCD: BM3 BM7;3DMET: B04710;NIKKAJI: J149.444I
C00559,C10H13N5O3,251.2419,251.1018,Purine metabolism;Metabolic pathways,Deoxyadenosine;2'-Deoxyadenosine,R02088 R02089 R02556 R02557,R02088 R02089 R02556 R02557,Compounds with biological roles [BR:br08001]; Nucleic acids;  Nucleosides;   Deoxyribonucleosides;    C00559  Deoxyadenosine (dA),CAS: 958-09-8;PubChem: 3839;ChEBI: 17256;ChEMBL: CHEMBL449329;KNApSAcK: C00019281;PDB-CCD: 3D1;3DMET: B01287;NIKKAJI: J80.042B
C00575,C10H12N5O6P,329.2059,329.0525,"Purine metabolism;Endocrine resistance;Biofilm formation - Pseudomonas aeruginosa;Biofilm formation - Escherichia coli;MAPK signaling pathway;Ras signaling pathway;Rap1 signaling pathway;Calcium signaling pathway;cGMP-PKG signaling pathway;cAMP signaling pathway;Chemokine signaling pathway;Phospholipase D signaling pathway;Cell cycle - yeast;Meiosis - yeast;Oocyte meiosis;Longevity regulating pathway;Longevity regulating pathway - multiple species;Adrenergic signaling in cardiomyocytes;Vascular smooth muscle contraction;Hedgehog signaling pathway;Apelin signaling pathway;Gap junction;Platelet activation;Leukocyte transendothelial migration;Circadian rhythm;Circadian entrainment;Thermogenesis;Long-term potentiation;Retrograde endocannabinoid signaling;Glutamatergic synapse;Cholinergic synapse;Serotonergic synapse;GABAergic synapse;Dopaminergic synapse;Olfactory transduction;Taste transduction;Inflammatory mediator regulation of TRP channels;Insulin signaling pathway;Insulin secretion;GnRH signaling pathway;Ovarian steroidogenesis;Progesterone-mediated oocyte maturation;Estrogen signaling pathway;Melanogenesis;Thyroid hormone synthesis;Thyroid hormone signaling pathway;Oxytocin signaling pathway;Glucagon signaling pathway;Regulation of lipolysis in adipocytes;Renin secretion;Aldosterone synthesis and secretion;Relaxin signaling pathway;Cortisol synthesis and secretion;Parathyroid hormone synthesis, secretion and action;Cushing syndrome;Aldosterone-regulated sodium reabsorption;Endocrine and other factor-regulated calcium reabsorption;Vasopressin-regulated water reabsorption;Salivary secretion;Gastric acid secretion;Pancreatic secretion;Bile secretion;Parkinson disease;Prion diseases;Cocaine addiction;Amphetamine addiction;Morphine addiction;Alcoholism;Vibrio cholerae infection;Biofilm formation - Vibrio cholerae;Pertussis;Chagas disease (American trypanosomiasis);Amoebiasis;Human papillomavirus infection;Human T-cell leukemia virus 1 infection;Pathways in cancer;Dilated cardiomyopathy (DCM)","3',5'-Cyclic AMP;Cyclic adenylic acid;Cyclic AMP;Adenosine 3',5'-phosphate;Adenosine 3',5'-cyclic phosphate;cAMP",R00089 R00191 R11619,R00089 R00191 R11619,"Compounds with biological roles [BR:br08001]; Nucleic acids;  Cyclic nucleotides;   3',5'-Cyclic nuclcleotides;    C00575  3',5'-Cyclic AMP",CAS: 60-92-4;PubChem: 3854;ChEBI: 17489;ChEMBL: CHEMBL316966;KNApSAcK: C00001497;PDB-CCD: CMP;3DMET: B01289;NIKKAJI: J4.811I
C04677,C9H15N4O8P,338.2112,338.0628,Purine metabolism;Histidine metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from histidine and purine;Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of antibiotics;AMPK signaling pathway,1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide;5'-Phosphoribosyl-5-amino-4-imidazolecarboxamide;5'-Phospho-ribosyl-5-amino-4-imidazole carboxamide;AICAR;5-Aminoimidazole-4-carboxamide ribotide;5-Phosphoribosyl-4-carbamoyl-5-aminoimidazole;5-Amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide;5-Amino-1-(5-phospho-beta-D-ribosyl)imidazole-4-carboxamide,R04378 R04558 R04559 R04560 R06975 R12152,R04378 R04558 R04559 R04560 R06975 R12152,,CAS: 3031-94-5;PubChem: 7258;ChEBI: 18406;ChEMBL: CHEMBL483849;KNApSAcK: C00007383;PDB-CCD: AMZ;3DMET: B01774;NIKKAJI: J7.665A
C01081,C12H18N4O4PS,345.3345,345.0786,Thiamine metabolism;Metabolic pathways,Thiamin monophosphate;Thiamine monophosphate;Thiamin phosphate;Thiamine phosphate;TMP,R00615 R00617 R02134 R02135 R03223 R10712 R11312,R00615 R00617 R02134 R02135 R03223 R10712 R11312,,PubChem: 4319;ChEBI: 9533;ChEMBL: CHEMBL1236378;KNApSAcK: C00019628;PDB-CCD: TPS;3DMET: B00237;NIKKAJI: J221.489J
C02140,C21H30O4,346.4605,346.2144,Steroid hormone biosynthesis;Metabolic pathways;Regulation of lipolysis in adipocytes;Aldosterone synthesis and secretion;Prion diseases,"Corticosterone;11beta,21-Dihydroxy-4-pregnene-3,20-dione;Kendall's compound B;Reichstein's substance H",R03262 R03847 R03848 R03849 R03850 R03851,R03262 R03847 R03848 R03849 R03850 R03851,"Compounds with biological roles [BR:br08001]; Steroids;  21-Carbon atoms;   Pregnane derivatives;    C02140  Corticosterone; Hormones and transmitters;  Steroid hormones;   Mineralocorticoids;    C02140  Corticosterone;Lipids [BR:br08002]; ST  Sterol Lipids;  ST02 Steroids;   ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;    C02140  Corticosterone",CAS: 50-22-6;PubChem: 5219;ChEBI: 16827;ChEMBL: CHEMBL110739 CHEMBL1513569;LIPIDMAPS: LMST02030186;LipidBank: SST0168;PDB-CCD: C0R;3DMET: B01538;NIKKAJI: J5.239F
C00362,C10H14N5O7P,347.2212,347.0631,Purine metabolism;Metabolic pathways,dGMP;2'-Deoxyguanosine 5'-monophosphate;2'-Deoxyguanosine 5'-phosphate;Deoxyguanylic acid;Deoxyguanosine monophosphate,R01855 R01967 R01968 R02090,R01855 R01967 R01968 R02090,Compounds with biological roles [BR:br08001]; Nucleic acids;  Nucleotides;   Deoxyribonucleotides;    C00362  dGMP,CAS: 902-04-5;PubChem: 3653;ChEBI: 16192;ChEMBL: CHEMBL477487;KNApSAcK: C00019356;PDB-CCD: DG DGP;3DMET: B01228;NIKKAJI: J195.198J
C00735,C21H30O5,362.4599,362.2093,Steroid hormone biosynthesis;Metabolic pathways;Neuroactive ligand-receptor interaction;Cortisol synthesis and secretion;Cushing syndrome;Aldosterone-regulated sodium reabsorption;Bile secretion;Pathways in cancer;Prostate cancer;Glucocorticoid and mineralocorticoid receptor agonists/antagonists,"Cortisol;Hydrocortisone;11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione;Kendall's compound F;Reichstein's substance M",R02834 R02836 R02837 R02838 R02839 R02840 R02841 R02843;R08995,R02834 R02836 R02837 R02838 R02839 R02840 R02841 R02843;R08995,"Compounds with biological roles [BR:br08001]; Steroids;  21-Carbon atoms;   Pregnane derivatives;    C00735  Cortisol; Hormones and transmitters;  Steroid hormones;   Glucocorticoids;    C00735  Cortisol;Lipids [BR:br08002]; ST  Sterol Lipids;  ST02 Steroids;   ST0203 C21 steroids (gluco/mineralocorticoids, progestogens) and derivatives;    C00735  Cortisol;Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]; A ALIMENTARY TRACT AND METABOLISM;  A01 STOMATOLOGICAL PREPARATIONS;   A01A STOMATOLOGICAL PREPARATIONS;    A01AC Corticosteroids for local oral treatment;     A01AC03 Hydrocortisone;      D00088  Hydrocortisone (JP17/USP/INN) &lt;JP/US&gt;;  A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS;   A07E INTESTINAL ANTIINFLAMMATORY AGENTS;    A07EA Corticosteroids acting locally;     A07EA02 Hydrocortisone;      D00088  Hydrocortisone (JP17/USP/INN) &lt;JP/US&gt;; C CARDIOVASCULAR SYSTEM;  C05 VASOPROTECTIVES;   C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE;    C05AA Corticosteroids;     C05AA01 Hydrocortisone;      D00088  Hydrocortisone (JP17/USP/INN) &lt;JP/US&gt;; D DERMATOLOGICALS;  D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS;   D07A CORTICOSTEROIDS, PLAIN;    D07AA Corticosteroids, weak (group I);     D07AA02 Hydrocortisone;      D00088  Hydrocortisone (JP17/USP/INN) &lt;JP/US&gt;;   D07X CORTICOSTEROIDS, OTHER COMBINATIONS;    D07XA Corticosteroids, weak, other combinations;     D07XA01 Hydrocortisone;      D00088  Hydrocortisone (JP17/USP/INN) &lt;JP/US&gt;; H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS;  H02 CORTICOSTEROIDS FOR SYSTEMIC USE;   H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN;    H02AB Glucocorticoids;     H02AB09 Hydrocortisone;      D00088  Hydrocortisone (JP17/USP/INN) &lt;JP/US&gt;; S SENSORY ORGANS;  S01 OPHTHALMOLOGICALS;   S01B ANTIINFLAMMATORY AGENTS;    S01BA Corticosteroids, plain;     S01BA02 Hydrocortisone;      D00088  Hydrocortisone (JP17/USP/INN) &lt;JP/US&gt;;   S01C ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION;    S01CB Corticosteroids/antiinfectives/mydriatics in combination;     S01CB03 Hydrocortisone;      D00088  Hydrocortisone (JP17/USP/INN) &lt;JP/US&gt;;  S02 OTOLOGICALS;   S02B CORTICOSTEROIDS;    S02BA Corticosteroids;     S02BA01 Hydrocortisone;      D00088  Hydrocortisone (JP17/USP/INN) &lt;JP/US&gt;;USP drug classification [BR:br08302]; Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal);  Hydrocortisone;   D00088  Hydrocortisone (JP17/USP/INN);  Hydrocortisone;   D00088  Hydrocortisone (JP17/USP/INN);  Hydrocortisone;   D00088  Hydrocortisone (JP17/USP/INN); Inflammatory Bowel Disease Agents;  Glucocorticoids;   Hydrocortisone;    D00088  Hydrocortisone (JP17/USP/INN);Therapeutic category of drugs in Japan [BR:br08301]; 2  Agents affecting individual organs;  24  Hormones;   245  Adrenal hormone preparations;    2452  Cortisones;     D00088  Hydrocortisone (JP17/USP/INN);Classification of Japanese OTC drugs [BR:br08313]; Agents for integumentary system;  57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches);   D00088  Hydrocortisone (JP17/USP/INN);Risk category of Japanese OTC drugs [BR:br08312]; Designated second-class OTC drugs;  Inorganic and organic chemicals;   Hydrocortisone;    D00088  Hydrocortisone (JP17/USP/INN); Second-class OTC drugs;  Inorganic and organic chemicals;   Hydrocortisone;    D00088  Hydrocortisone (JP17/USP/INN);Target-based classification of drugs [BR:br08310]; Nuclear receptors;  Estrogen like receptors;   3-Ketosteroid receptor;    NR3C1 (GR);     D00088  Hydrocortisone (JP17/USP/INN) &lt;JP/US&gt;;Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D00088  Hydrocortisone;Drug classes of therapeutic agents [br08360.html]; Endocrine and hormonal agents;  D00088;Topical steroids potency [br08317.html]; Classification in the USA;  D00088;New drug approvals in Europe [br08329.html]; European public assessment reports (EPAR) authorised medicine;  D00088;Rx-to-OTC switch list in the USA [br08315.html]; D00088",CAS: 50-23-7;PubChem: 3998;ChEBI: 17650;ChEMBL: CHEMBL1092578 CHEMBL196519 CHEMBL389621;LIPIDMAPS: LMST02030001;LipidBank: SST0244;PDB-CCD: HCY;3DMET: B01319;NIKKAJI: J1.908I
C02946,C6H11NO3,145.1564,145.0739,Arginine and proline metabolism;Metabolic pathways,4-Acetamidobutanoate;N4-Acetylaminobutanoate,R01987 R05050,R01987 R05050,,PubChem: 5865;ChEBI: 11951 17645;3DMET: B00519;NIKKAJI: J35.110E
C01487,C6H12O6,180.1559,180.0634,Fructose and mannose metabolism;Microbial metabolism in diverse environments;ABC transporters,D-Allose,R03576,R03576,Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Aldoses;    C01487  D-Allose,CAS: 2595-97-3;PubChem: 4657;ChEBI: 4093;ChEMBL: CHEMBL1222152;PDB-CCD: AFD ALL;3DMET: B04798;NIKKAJI: J14.386C
C00124,C6H12O6,180.1559,180.0634,Galactose metabolism;Metabolic pathways;Bacterial chemotaxis;Phosphotransferase system (PTS);Carbohydrate digestion and absorption;Mineral absorption,D-Galactose;D-Galactopyranose,R01093 R01094 R01095 R01096 R01097 R01098 R01099 R01100;R01101 R01103 R01104 R01105 R01194 R01329 R01678 R02926;R03355 R03617 R03618 R03634 R04019 R04470 R04633 R05112;R05549 R05961 R05994 R06010 R06070 R06091 R06093 R06094;R06096 R06098 R06099 R06114 R06136 R06142 R06152 R06202;R07807 R08544 R10619 R10622 R11171,R01093 R01094 R01095 R01096 R01097 R01098 R01099 R01100;R01101 R01103 R01104 R01105 R01194 R01329 R01678 R02926;R03355 R03617 R03618 R03634 R04019 R04470 R04633 R05112;R05549 R05961 R05994 R06010 R06070 R06091 R06093 R06094;R06096 R06098 R06099 R06114 R06136 R06142 R06152 R06202;R07807 R08544 R10619 R10622 R11171,Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Aldoses;    C00124  D-Galactose,CAS: 59-23-4 10257-28-0;PubChem: 3424;ChEBI: 4139;ChEMBL: CHEMBL1233058 CHEMBL195923 CHEMBL300520;KNApSAcK: C00019681;PDB-CCD: GAL GLA;3DMET: B04637;NIKKAJI: J4.597G
C01494,C10H10O4,194.184,194.0579,Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Metabolic pathways;Biosynthesis of secondary metabolites,Ferulate;Ferulic acid;4-Hydroxy-3-methoxycinnamic acid;3-Methoxy-4-hydroxy-trans-cinnamate;4-Hydroxy-3-methoxycinnamate,R02194 R03366 R03579 R05700 R05701 R05744 R07292 R07440;R08839 R11071,R02194 R03366 R03579 R05700 R05701 R05744 R07292 R07440;R08839 R11071,Phytochemical compounds [BR:br08003]; Phenylpropanoids;  Monolignols;   Coniferyl alcohol derivatives;    C01494  Ferulate,CAS: 537-98-4;PubChem: 4664;ChEBI: 17620;ChEMBL: CHEMBL32749;KNApSAcK: C00002743 C00034325;PDB-CCD: FER;3DMET: B00304;NIKKAJI: J7.273G
C00089,C12H22O11,342.2965,342.1162,Galactose metabolism;Starch and sucrose metabolism;Metabolic pathways;ABC transporters;Phosphotransferase system (PTS);Taste transduction;Carbohydrate digestion and absorption,Sucrose;Cane sugar;Saccharose;1-alpha-D-Glucopyranosyl-2-beta-D-fructofuranoside,R00015 R00039 R00801 R00802 R00803 R00805 R00806 R00807;R00808 R00809 R00810 R00811 R01103 R01823 R02120 R02411;R04194 R05140 R07256 R08616 R08676,R00015 R00039 R00801 R00802 R00803 R00805 R00806 R00807;R00808 R00809 R00810 R00811 R01103 R01823 R02120 R02411;R04194 R05140 R07256 R08616 R08676,"Compounds with biological roles [BR:br08001]; Carbohydrates;  Oligosaccharides;   Disaccharides;    C00089  Sucrose; Cane sugar;Therapeutic category of drugs in Japan [BR:br08301]; 7  Agents not mainly for therapeutic purpose;  71  Dispensing medicines;   714  Flavorings, deodorants, coloring agents;    7149  Others;     D00025  Sucrose (JP17/NF); White soft sugar (JP17); Sugar, compressible (NF); Sugar, confectioner's (NF); Sugar spheres (NF);Risk category of Japanese OTC drugs [BR:br08312]; Third-class OTC drugs;  Inorganic and organic chemicals;   White soft sugar;    D00025  Sucrose (JP17/NF);Pharmaceutical additives in Japan [BR:br08316]; Stabilizing agent;  D00025  [001480] Sucrose;  D00025  [500313] White soft sugar; Lubricating agent;  D00025  [500313] White soft sugar; Sweetening agent;  D00025  [110635] Liquid sugar;  D00025  [001480] Sucrose;  D00025  [500313] White soft sugar; Base;  D00025  [001480] Sucrose;  D00025  [500313] White soft sugar; Flavoring substance;  D00025  [110635] Liquid sugar;  D00025  [001480] Sucrose;  D00025  [500313] White soft sugar;  D00025  [109287] Powdered sucrose; Bonding agent;  D00025  [001480] Sucrose;  D00025  [500313] White soft sugar; Brightening agent;  D00025  [001480] Sucrose; Coating agent;  D00025  [001480] Sucrose;  D00025  [500313] White soft sugar;  D00025  [109287] Powdered sucrose; Sugarcoated agent;  D00025  [001480] Sucrose;  D00025  [500313] White soft sugar; Diluting agent;  D00025  [001480] Sucrose;  D00025  [500313] White soft sugar;  D00025  [109287] Powdered sucrose; Disintegrant;  D00025  [001480] Sucrose;  D00025  [500313] White soft sugar; Dampproof agent;  D00025  [001480] Sucrose; Antiseptic agent;  D00025  [500313] White soft sugar; Solubilizer;  D00025  [500313] White soft sugar; Solubilization agent;  D00025  [500313] White soft sugar;Drugs listed in the Japanese Pharmacopoeia [BR:br08311]; Chemicals;  D00025  White soft sugar;  D00025  Sucrose",CAS: 57-50-1;PubChem: 3389;ChEBI: 17992;ChEMBL: CHEMBL253582;KNApSAcK: C00001151;PDB-CCD: SUC;3DMET: B01156;NIKKAJI: J4.581K
C02693,C10H10N2O,174.1992,174.0793,Tryptophan metabolism,(Indol-3-yl)acetamide;Indole-3-acetamide,R00679 R03096 R04020,R00679 R03096 R04020,,CAS: 879-37-8;PubChem: 5661;ChEBI: 16031;KNApSAcK: C00000108;PDB-CCD: TSR;3DMET: B00485;NIKKAJI: J128.124K
C00954,C10H9NO2,175.184,175.0633,Tryptophan metabolism;Biosynthesis of plant hormones;Metabolic pathways;Plant hormone signal transduction,Indole-3-acetate;Indole-3-acetic acid;(Indol-3-yl)acetate;Indoleacetate;Indoleacetic acid;IAA,R02678 R02681 R03092 R03093 R03094 R03095 R03096 R03097;R08609 R10181 R10452 R11730,R02678 R02681 R03092 R03093 R03094 R03095 R03096 R03097;R08609 R10181 R10452 R11730,Phytochemical compounds [BR:br08003]; Alkaloids;  Alkaloids derived from tryptophan and anthranilic acid;   Indole alkaloids;    C00954  Indole-3-acetate;Pesticides [BR:br08007]; Pesticides;  Plant growth regulators;   Auxins;    C00954  Indole-3-acetate,CAS: 87-51-4;PubChem: 4205;ChEBI: 16411;ChEMBL: CHEMBL82411;KNApSAcK: C00000100;PDB-CCD: IAC;3DMET: B00206;NIKKAJI: J5.156J
C03570,C6H13NO5,179.1711,179.0794,,D-Mannosamine;2-Amino-2-deoxy-D-mannose,,,Compounds with biological roles [BR:br08001]; Carbohydrates;  Monosaccharides;   Amino sugars;    C03570  D-Mannosamine,CAS: 14307-02-9;PubChem: 6362;ChEBI: 62324 62325;PDB-CCD: 95Z;3DMET: B04903;NIKKAJI: J133.219H
